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ABSTRACT 
 
Control of Cell Division by Nutrients, and ER Stress Signaling in Saccharomyces 
cerevisiae. (May 2007) 
Jinbai Guo, B.S., Northeast Agriculture University; M.S., Harbin Medical University 
Chair of Advisory Committee: Dr. Michael Polymenis 
 
Cell cycle progression of Saccharomyces cerevisiae cells was monitored in 
continuous cultures limited for glucose or nitrogen. The G1 cell cycle phase, before 
initiation of DNA replication, did not exclusively expand when growth rate decreased. 
Especially during nitrogen limitation, non-G1 phases expanded almost as much as G1. In 
addition, cell size remained constant as a function of growth rate. These results contrast 
with current views that growth requirements are met before initiation of DNA replication, 
and suggest that distinct nutrient limitations differentially impinge on cell cycle 
progression. Therefore, multiple mechanisms are hypothesized to regulate the 
coordination of cell growth and cell division. 
Genetic interactions were identified between the dose-dependent cell-cycle 
regulator 2 (DCR2) phosphatase and genes involving in secretion/unfolded protein 
response pathway, including IRE1, through a genome-wide dominant negative genetic 
approach. Accumulation of unfolded proteins in the endoplasmic reticulum triggers the 
unfolded protein response (UPR). How the UPR is downregulated is not well 
understood. Inositol requirement 1 (IRE1) is an endoplasmic reticulum transmembrane 
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UPR sensor in Saccharomyces cerevisiae. When the UPR is triggered, Ire1p is 
autophosphorylated, on Ser 840 and Ser 841, inducing the cytosolic endonuclease 
activity of Ire1p, thereby initiating the splicing and translational de-repression of HAC1 
mRNA. Homologous to Atf/Creb1 (Hac1p) activates UPR transcription. We found that 
that Dcr2p phosphatase functionally and physically interacts with Ire1p. Overexpression 
of DCR2, but not of a catalytically inactive DCR2 allele, significantly delays HAC1 
splicing and sensitizes cells to the UPR. Furthermore, Dcr2p physically interacts in vivo 
with Ire1p-S840E, S841E, which mimics phosphorylated Ire1p, and Dcr2p de-
phosphorylates Ire1p in vitro. Our results are consistent with de-phosphorylation of 
Ire1p being a mechanism for antagonizing UPR signaling. 
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CHAPTER I 
INTRODUCTION 
 
Our laboratory is mainly interested in studying how cell division is tightly 
coupled with cell growth in all proliferating cells, using the budding yeast 
Saccharomyces cerevisiae as our model system. Budding yeast is a genetically tractable 
eukaryotic organism, whose genome has been sequenced. In particular, yeast is a great 
model system for cell cycle studies for two reasons: First, the fundamental mechanisms 
of cell cycle regulation are evolutionarily conserved between yeast and mammalian 
organisms; Second, the appearance of buds is a unique morphological marker to tell if 
cells are committed to a new round of cell division. 
 
THE CELL CYCLE 
The cell cycle, or cell-division cycle (CDC), consists of a series of continuous 
events, in which the cellular components are duplicated and ultimately equally 
segregated into two healthy and viable daughter cells. Based on the characteristics of 
cellular biology and physiology, mainly the behavior of chromosomes, the cell cycle of 
animal cells can be divided into four distinct phases: G1 phase, S phase, G2 phase 
(collectively known as interphase) and M phase. M phase is featured with chromosome 
condensation and equal segregation and ended in cytokinesis, in which the cytoplasm  
__________________________ 
This dissertation follows the style and format of Cell. 
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(containing cellular organelles) physically divides. The interphase involves obtaining 
nutrients, duplication of genetic material and organelles, reorganization of the 
cytoskeleton, and formation of the mitotic spindle. In G1 phase, the cell grows in mass 
and prepares for the next cell cycle; in S phase, the chromosomes are duplicated; in G2 
phase, the cell continues to grow in preparation for cell division. 
Likewise, the cell cycle of the budding yeast, Saccharomyces cerevisiae, can also 
be divided into four comparable phases under the same parameters, G1, S, G2 and M 
phase. Cells in G1 are sensitive to external stimuli, such as availability of nutrients and 
the presence of anti-mitogenic stimuli. Under poor nutrient conditions, cells arrest in the 
G1 phase, and diploid cells may undergo sporulation. Exposure to anti-mitogenic 
stimuli, such as mating pheromones, high salt conditions or some chemicals, arrests cells 
in late G1 phase. If the external environment is acceptable, cells grow to meet their 
physiological requirements until initiation of the next round of cell division. Hence, G1 
phase is generally seen as the limiting step for overall cell proliferation, and the 
observation that cell proliferation rates correlate with the duration of G1 phase has led to 
the important concept of START (or the Restriction Point). START is a point in late G1 
when various aspects of the cell’s physiology are measured and monitored. Passage 
through START ensures that growth requirements are met before the cell is committed 
to the next division (Pringle and Hartwell, 1981). The completion of START is normally 
concomitant with the transition from G1 to S phase, which is marked with several 
landmark events like initiation of DNA replication, duplication of the microtubule-
organizing center called a spindle pole body (SPB) and appearance of a bud on the 
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surface. Subsequently, chromosomes are duplicated in S phase; after G2 phase, cells 
proceed to M phase. 
Budding yeast undergoes closed mitosis where the nuclear membrane remains 
intact throughout M phase (Murray and Hunt, 1993). The bipolar spindle is assembled 
inside the nuclear membrane, and the nucleus then divides into two nuclei after 
chromosome segregation. Mitosis ends with cytokinesis, where an asymmetric division 
gives rise to a smaller daughter cell and a larger mother cell (Hartwell and Unger, 1977). 
 
CELL GROWTH AND CELL DIVISION 
The general cellular parameters, such as overall cell size and macromolecular 
composition, remain relatively constant for all proliferating cells during successive cell 
division cycles. This is true for all living organisms (from bacteria to humans). These 
general cellular physiological phenomena strongly indicate the tight coordination 
between overall cell growth and cell division. However, the molecular mechanisms of 
how cell growth is tightly coupled with cell division are mostly unclear and debatable. 
The following illustrates how we view this question. (For simplicity, the discussion will 
be only focusing on unicellular organisms like budding yeast.) 
For clarification and convenience, cell growth refers to increases of biomass 
(e.g., size and/or weight), measured as doubling time of total biomass.The rate of 
increase of macromolecules (e.g., total RNA and protein) but exclusive of DNA 
determines whether cell growth is fast or slow, and it is dependent on the total metabolic 
activity of cell. Cell division refers to the doubling of DNA, which is coupled to mitosis 
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once DNA synthesis begins. Fast or slow transition among four sequential cell division 
phases is determined by the duration of each phase relative to the overall doubling time. 
Thus, comparisons of cell cycle transitions can only be properly done when there is no 
significant difference of the overall doubling time. Following these definitions of cell 
growth and cell division, we could simplify three scenarios of how cell growth is 
coupled with cell division (Neufeld and Edgar, 1998; Polymenis and Schmidt, 1999): 
growth and division are independent of each other; division controls growth; or growth 
controls division. These are not mutually exclusive, and they may somehow integrate 
together, depending on different internal and external environments. I outline each 
scenario below. 
First, cell growth and cell division may work in parallel during cell proliferation, 
in other words, they could work independently in some cases. Indeed, rat Schwann cell 
growth can continue to increase cell volume up to nearly 5 fold when cell division is 
blocked (Conlon and Raff, 2003), arguing that cell division does not control cell growth; 
Early Xenopus embryos can undergo 12 successive cell divisions without significant 
changes of overall biomass, arguing that cell growth is not limiting for cell division in 
early embryogenesis. Interestingly, cell size of budding yeast under continuous culture 
conditions does not vary as a function of the growth rate but as function of nutrient 
composition (Chapter III) (Guo et al., 2004). Therefore, the biomass or cell size cannot 
be the exclusive parameter to evaluate for the coordination of cell growth and cell 
division, though it does provide a useful parameters in pursuing this question. Most 
studies assume that unlike many key cell cycle regulators that oscillate throughout the 
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cell cycle, metabolsm does not oscillate during the cell cycle. Yet metabolic programs 
also display nice controlled periodic cycles, such as O2 consumption, CO2 excretion, 
NADH and H2S (Lloyd et al., 2003; Lloyd and Murray, 2006; Tu et al., 2005; Tu and 
McKnight, 2006). Microarray studies reveal that essential cellular and metabolic events 
occur in synchrony with the metabolic cycle (Tu et al., 2005). It will be worth studying 
further the connection between cell cycle oscillation and metabolic cycles. Some genes, 
such as those targeted by C-myc, are known to control both cell growth and division 
(Polymenis and Schmidt, 1999). 
Second, cell division might regulate cell growth during cell proliferation. The 
three G1 cyclins of budding yeast contribute differently to the fitness of the population 
in nitrogen-limiting continuous cultures (Bryan et al., 2004). Furthermore, loss of G1 
cyclins, or inactivation of the cyclin-dependent kinase Cdc28p, reduced the activity of 
glutamate synthetase (Glt1p), a key enzyme in nitrogen assimilation, suggesting that 
completion of START may be linked to nitrogen metabolism (Bryan et al., 2004). Given 
that about 13% of non-histones, 20% of histone, 15.75% of DNA and 14.95% of RNA 
mass is nitrogen, it won’t be a surprise that to initiate cell division, the cell needs to up-
regulate nitrogen metabolism. Additionally, it might be a self-supporting mechanism, 
because cells need to guarantee that their biosynthetic requirements will be met for 
chromosome duplication and cell cycle completion, since passage through START is 
basically a commitment and “no return” action.  
Third, cell growth controls cell division during cell proliferation. This scenario is 
very well accepted for the coordination of cell growth with cell division. In most cases, 
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when cell growth is limited, such as under poor nutrient conditions, there is not only an 
extension of the overall doubling time, but also it is most strikingly visible in the length 
of G1 phase, before DNA replication. In other words, cell division seems to be mostly 
controlled at the G1 phase. Therefore, it is believed that the cell cycle profile (more 
strictly, the duration of G1 phase) would be identical for cells growing at the same rate, 
because the critical growth rate and nutrient requirements have to be reached in G1 
(Pringle and Hartwell, 1981). However, we demonstrate that the G1 phase of budding 
yeast only predominantly expands as the growth rate declines in glucose-limiting 
continuous cultures, but not in nitrogen-limiting continuous cultures, where all cell cycle 
phases appear to proportionally expand (not only G1). These results indicate that cell 
growth is controlled in a nutrient-specific manner and cannot be exclusively monitored 
at START (Chapter III) (Guo et al., 2004). Therefore, cell cycle phases besides G1 
should be included in studies of coordination of cell growth and cell division, especially 
since cell growth is a continuous process. Cell growth limitations might primarily 
become evident in G1 simply because during the previous phases of cell cycle there is a 
continuous accumulation of molecules necessary for the G1/S transition. 
 
CURRENT MODELS FOR COORDINATION OF CELL GROWTH WITH 
CELL DIVISION 
Current studies of the coordination of cell growth with cell division are mostly 
focusing on size and G1 phase. It is thought that cells have to grow to a critical cell size 
before they can initiate division during the normal cell cycle. Budding yeast undergoes 
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asymmetric division, where the daughters are usually born smaller than the mothers, thus 
daughter cells have to spend more time in G1 phase to grow more to reach the critical 
size. This is thought to maintain size homeostasis. Protein synthesis and, in particular, 
ribosome biogenesis is thought to determine initiation of cell division, but the two 
prevailing models for such a control reach opposite conclusions. 
The first model is called the “Cln3p abundance model”. This model centers 
around the G1 cyclin Cln3p. Over-expressing CLN3 induces a smaller size, shorter G1 
phase, and START is accelerated. Conversely, deletion of CLN3 leads to larger size, 
longer G1 and START is delayed. Note however that small or large cell size due to gain 
or loss of CLN3 primarily derives from disproportional changes of vacuole size (Han et 
al., 2003), adding more complexity. Nonetheless, a short upstream open reading frame 
(uORF) in the 5’ leader of CLN3 mRNA causes its translational repression in media with 
a poor carbon source, when the concentration of ribosomes is low (Polymenis and 
Schmidt, 1997), thus delaying completion of START. Therefore, Cln3p can serve as an 
ideal mediator between growth conditions and the cell cycle machinery. However, as 
discussed previously, the length of G1 can be varied independent of growth rate and cell 
size (Chapter III), other phases need to be considered as well. Hence, modulation of 
Cln3p levels cannot fully explain the coordination of cell growth with cell division. 
The second model is called the “nutrient modulation of critical cell size threshold 
model” (Jorgensen et al., 2004). The model proposed that increased ribosome content 
suppresses completion of START so that cells can grow to a larger size before they can 
initiate division; in contrast, ribosomal biogenesis mutants, with a decreased ribosome 
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content, can undergo cell division at a smaller size, thus passage through START is 
accelerated. However, sfp1∆ (encoding a transcription factor involved in expression of 
ribosomal proteins) and sch9∆ (encoding a kinase important for ribosome biogenesis) 
cells proliferate slowly, and their G1 phases are greatly prolonged: sch9 mutants by 35% 
and sfp1 mutants by 280% (Jorgensen et al., 2004). Thus, despite their small cell size, 
the timing of START is actually significantly delayed in these mutants compared to wild 
type. 
The common questionable part of these two models is that they seemed only to 
stress one parameter but overlook another. The “Cln3p abundance model” uses the 
duration of G1 to evaluate fast or slow cell cycle progression, but ignores the cell size 
changes. On the other hand, the “nutrient modulation of critical cell size threshold 
model” only emphasizes the critical size, but overall proliferation is actually much 
slower than wild type. 
From our previous discussion, it can be seen how complex this question is, and it 
can hardly be explained by one model. It won’t be surprising if coordination of cell 
growth with cell division is regulated by multiple mechanisms, which might add 
“plasticity”. One mechanism could be quickly switched to another, following internal 
or/and external changes of conditions, allowing for either cell growth or cell division to 
completely stop, while the other process is still ongoing. Unlike the well-controlled 
conditions in our research labs, cells, especially from unicellular organisms, need the 
ability to cope with unexpected “noise” in the environment. Interestingly, cells within a 
genetically-uniform population can exhibit striking phenotypic variability. Also, no 
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matter how well a cell population can be synchronized, they will be asynchronous again 
within a few rounds of divisions. Nevertheless, the tight coordination between cell 
growth and division determines when cells initiate cell division. Therefore, gene 
products, which can promote the completion of START, will definitely help us 
understand how the coordination is achieved. 
 
SCREEN FOR NOVEL REGULATORS OF START 
Previously, two types of genetic screens were done to identify regulators of 
START, which relied on cell size changes (Jorgensen et al., 2002; Prendergast et al., 
1990; Sudbery et al., 1980; Zhang et al., 2002) and resistance to pheromone (Cross, 
1988; Edwards et al., 1997; Reed, 1980). However, cell size can be regulated 
independently of cell cycle progression, and cells continue to grow in the presence of 
pheromone though they don’t divide, thereby disturbing the normal coordination of cell 
growth with cell division. Thus, there must be other unknown factors involved the 
regulation of START. 
Hence, a screen was performed in our lab to identify genes that shorten the G1 
phase in a dosage-dependent manner. The screen used a novel mechanical enrichment 
procedure without significantly perturbing normal cellular physiology. It totally relies on 
the timing of START without depending on alterations of cell size or pheromone 
resistance (Bogomolnaya et al., 2004a). After the screen, several gene products were 
identified and shown to accelerate the G1/S transition when over-expressed. They are 
GID8 (Glucose Induced Degradation), DCR2 (Dosage dependent Cell cycle Regulator), 
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HYM1 (HYpha-like Metulae 1) and KEM1 (Kar1-1 nuclear-fusion-defect Enhancing 
Mutation) (Bogomolnaya et al., 2004b; Bogomolnaya et al., 2006; Pathak et al., 2004; 
Pathak et al., 2005). 
 
Dcr2p PHOSPHATASE 
The Dosage-dependent Cell cycle Regulator gene DCR2 contains a GNHD/E 
sequence motif, which is in the calcineurin-like metal-containing phosphoesterases (E 
value = 1e−5) (Geer et al., 2002), and thought to be important for the hydrolysis of 
phosphate esters in the active-site dinuclear metal center. Thus Dcr2p is a putative 
phosphatase. A histidine to alanine substitution in the GNHD/E motif still allows 
substrate binding but impairs catalytic activity in  Ser/Thr phosphatase and calcineurin 
(Mertz et al., 1997) (Zhuo et al., 1994). When histidine 338 is mutated to alanine in 
Dcr2p’s GNHD/E motif, a dominant-negative variant (Dcr2p-H338A, or Dcr2pDN) is 
generated. Indeed, Dcr2pDN can significantly antagonize the wild type function of Dcr2p 
in accelerating cell cycle progression (Pathak et al., 2004). Further functional analysis 
indicated that DCR2 and GID8 work in a common pathway, in a dosage-dependent 
manner, to promote START (Pathak et al., 2004).  
To further investigate the biological function of Dcr2p, a genome-wide genetic 
screen utilizing this dominant negative allele (DCR2DN) was done. The screen intended 
to identify genes that have synthetic sick or lethal effects with DCR2, suggesting that 
genetically these two genes contribute towards the same biological function. Through 
this genome-wide dominant-negative approach, we interrogated 4,021 deletion strains. 
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Finally, 12 genes were validated to have genetic interaction with DCR2. Nine of them 
have putative roles in trafficking and unfolded protein response caused by ER stress, 
indicating a physiological function of Dcr2p. 
 
ER STRESS 
The endoplasmic reticulum (ER) plays an essential role in the biosynthesis of 
proteins destined for secretion or membrane insertion in eukaryotes (Back et al., 2005; 
Schneider et al., 2004). This membrane-bound organelle, which associates with 
translating ribosomes and translocates peptides into its lumen, is a processing plant to 
promote a variety of post-translational modifications and chaperone-facilitated folding 
events. Proteins must be correctly folded and assembled in the ER prior to transit to 
intracellular organelles and the cell surface. In addition, by serving as the primary site at 
which client proteins enter the secretory compartment and as the site of synthesis and 
assembly of the lipid bi-layer, the ER indirectly controls the capacity and scope of the 
entire endomembrane/endocytic system. Therefore, the endoplasmic reticulum is 
exquisitely sensitive to alterations of cellular homeostasis. At any given time, the load of 
client proteins that the ER must handle is kept at a balance with trafficking of client 
proteins into the secretory pathway that the ER should promote, which is set by 
developmental programs and modulated by physiological stimuli. As a result, when the 
influx of nascent, unfolded polypeptides exceeds the folding and/or processing capacity 
of the ER, and/or if the secretory processes are blocked, the normal physiological state 
of the ER is perturbed, resulting in the accumulation of unfolded proteins in the ER. This 
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is called ER stress, primarily due to the toxic effect of the accumulating unfolded 
proteins, which constitutes a fundamental threat to the cells. In other words, ER stress is 
defined functionally as an imbalance between the load of client proteins facing the ER 
and the organelle’s ability to process that load. 
ER stress can be triggered under a number of cellular stress conditions, such as 
perturbations in calcium homeostasis or redox status, sugar/glucose deprivation, elevated 
protein synthesis, expression of misfolded proteins and blocked secretory pathway (Lee, 
1992). Mutations impairing the client protein folding or chemicals that disturb the 
protein folding can cause ER stress (Gething and Sambrook, 1992), such as blocking 
glycosylation with tunicamycin, or inhibiting disulfide bond formation with 
dithiothreitol. Since ER is the site of the synthesis of sterols and lipids, the perturbations 
in lipid metabolism can also cause an ER stress response, but very little is known about 
the mechanism of its activation by perturbations in lipid metabolism. In mammals, ER 
stress can be provoked by a variety of pathophysiological conditions, for example, 
ischemia, hyperhomocystinemia and viral infections (Aridor and Balch, 1999; Kaufman, 
1999). The phenotypes resulting from mutations affecting components of the ER stress 
response machinery reveal that ER stress is also a normal physiological phenomenon 
(Harding et al., 2001). 
 
UNFOLDED PROTEIN RESPONSE 
Eukaryotic cells have evolved specific signaling pathways and effector 
mechanisms to deal with ER stress. By the late 1980s, it had been known that there is a 
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specific link between manipulations that perturb protein folding in the ER and the 
induction of a class of mRNAs that encode ER chaperones (Hendershot et al., 1988; 
Kozutsumi et al., 1989; Kozutsumi et al., 1988). Although this gene expression program 
was highly reminiscent of the well characterized heat-shock response, which couples 
perturbation in the folded state of cytoplasmic proteins with the activation of genes that 
restore homeostasis to the cytoplasmic folding environment, the ER chaperone–encoding 
genes are not induced by heat shock (Kozutsumi et al., 1988). This suggests the presence 
of a compartment-specific signaling pathway that couples events in the lumen of the ER 
to changes in gene expression in the nucleus. Because this trans-organelle signaling 
pathway is activated experimentally by manipulations that impede protein folding in the 
ER or by expression of mutant ER client proteins impaired in their ability to fold, it was 
named the unfolded protein response (UPR) signaling pathway. Now it is believed that 
the UPR signaling pathway is more likely triggered by the threat of their accumulation, 
not by the malfolded/unfolded proteins themselves. 
Because of the nature of ER stress, the UPR signaling pathway should primarily 
serve for one major mission, that is to re-balance the load of client proteins with the 
capacity of ER, thus recovering ER homeostasis. Therefore, UPR signaling should be 
able to (1) sense the signals of ER stress; (2) transduce them into effectors; (3) turn on 
target genes. It can also be imagined that there are likely two ways for the UPR signaling 
pathway to recover the normal status of ER, either by promoting protein folding inside 
the ER and boosting secretion from the ER, or by decreasing the loading of protein into 
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the ER, such as attenuating protein synthesis. Indeed, all the UPR signaling pathways 
identified so far, have exactly these characteristics. 
Several components of the UPR have been identified during the last decade. 
They either integrate in a linear pathway or work in a parallel manner. The basic 
components of the UPR pathway were first characterized in the budding yeast, 
Saccharomyces cerevisiae, in the early 1990s. Ire1p/Ern1p, which was first identified in 
a genetic screen for Inositol Requiring genes in budding yeast, is an ER transmembrane 
protein kinase/endoribonuclease. It is a transducer that initiates UPR signaling and it is 
essential for cell survival during ER stress (Cox et al., 1993; Mori et al., 1993). 
Thereafter, researchers found that all eukaryotic cells have conserved the essential and 
unique properties of Ire1p-mediated UPR signaling pathway as the one identified in 
yeast, but also evolved additional transducers to generate a diversity of responses. In 
mammals, the counterpart of yeast Ire1p has two isoforms: IRE1α and IRE1β. Whereas 
IRE1α is expressed in most cells and tissues, IRE1β expression is primarily restricted to 
the intestinal epithelial cells (Hemminki et al., 1998; Welihinda et al., 1998). In addition 
to IRE1, higher eukaryotic cells have two additional UPR transducers: the double-
stranded RNA-activated protein kinase-like ER kinase (PERK) and activating 
transcription factor 6 (ATF6). The UPR signaling pathways include both translational 
and transcriptional responses. Overall, translational response is mediated by PERK; 
transcriptional response is mediated through ATF6 and IRE1. 
PERK contains a large ER luminal stress-sensing domain that is functionally 
interchangeable with the IRE1 luminal domain and a cytosolic kinase domain. When ER 
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stress is sensed from the ER lumen, PERK can specifically phosphorylate the αsubunit 
of eukaryotic translation initiation factor 2 (eIF2α) on Serine 51 (Harding et al., 1999; 
Liu et al., 2000). This phosphorylation of eIF2 inhibits eIF2B, the GTP exchange 
factor, to change GDP-binding form of eIF2 into GTP-binding form (Dever, 2002), 
thus repressing the reutilization of eIF2 and initiation of translation. Therefore, one 
direct consequence of the phosphorylation of eIF2 by PERK upon ER stress is to 
attenuate translation activities globally, thus decreasing the protein load to the ER. This 
is a very convenient and efficient way to control translation initiation, coupling stress 
response signaling pathways to block cellular protein synthesis through eIF2 (Harding 
et al., 2002). For example, the typical analogue is that GCN2 and HRI phosphorylate 
eIF2 in amino acid starved cells. Interestingly, some UPR target genes, such as ATF4, 
have several small open reading frames at their 5 end, called upstream open reading 
frames (uORFs), which mediate basal repression of their translation. Under conditions of 
eIF2 phosphorylation, these mRNAs are translated more efficiently (Scheuner et al., 
2001). Thus, another consequence of phosphorylation of eIF2 by PERK upon ER stress 
is to specifically up-regulate a certain group of UPR target genes. 
ATF6, a member of the ATF/CREB protein family, is a transcription factor with 
an N-terminal basic leucine zipper (b-ZIP) domain in the cytosol and a C-terminal ER 
luminal domain to sense stress (Haze et al., 1999). ATF6 is constitutively synthesized as 
an ER membrane protein. The ER membrane-associated ATF6 is inactive for 
transcription. When the signals of ER stress are sensed from the ER lumen, ATF6 is first 
translocated into the Golgi apparatus. Then, its cytosolic domain, containing the DNA-
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binding and transcriptional activation domains, is proteolytically cleaved off and then 
transported to the nucleus to specifically activate transcription of UPR target genes 
(Yoshida et al., 2000). 
 
IRE1-MEDIATED UPR SIGNALING PATHWAY 
The IRE1-mediated UPR signaling pathway, first identified in Saccharomyces 
cerevisiae, is evolutionarily conserved in eukaryotic organisms (from yeast to mammals), 
and plays a central role in ER stress. In both budding yeast and mammals the pathway 
works in an almost identical manner. It is mainly composed of an ER transmembrane 
protein kinase (Ire1p) and a specific bZIP transcription factor, Hac1p in yeast or XBP-1 
in humans, serving as a downstream target (Zhang and Kaufman, 2004). 
Ire1p localizes across the ER membrane and can be dissected into three 
functional domains. First, the amino-terminal domain resides in the ER lumen, and plays 
a major role in sensing the accumulation of unfolded proteins. Second, after the 
transmembrane linker region of Ire1p, there is an atypical serine/threonine kinase 
domain in its upper cytosolic region, which phosphorylates itself in trans after being 
activated. Third, the C-terminal tail is an endoribonuclease domain showing strong 
homology to RNase L. 
The mechanism of how Ire1p’s ER-lumenal domain (LD) senses unfolded 
proteins is still controversial. Both yeast Ire1p LD’s and human IRE1α LD’s crystal 
structures have been solved recently (Credle et al., 2005; Zhou et al., 2006), and they are 
very similar. This is not a surprising since there is high degree of conservation between 
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their amino acid sequences. Both of them adopt the formation of the MHC-like groove. 
However, the size of the groove of human Ire1p LD is too narrow to permit peptide 
binding as being proposed from yeast Ire1p LD, and the key residues in the groove also 
function differently. Nevertheless, both crystal structures support the notion that homo-
dimerization or oligomerization (possibly through direct interaction with unfolded 
proteins) is the prerequisite step for activating the response, because mutations on their 
surfaces of dimerization compromise the response. Interestingly, there is a constitutively 
ON version of IRE1 in yeast, called IRE1C, which carries mutations in its LD region 
(Travers et al., 2000). Therefore, both biochemical and genetic analysis indicate that 
UPR activation has to be initiated from Ire1p’s LD; additionally, a common mechanism 
of activation is likely to exist due to the fact of functionally exchangeable ER lumenal 
domain among yeast Ire1p, human Ire1p and even human PERK (Liu et al., 2000). 
After the signal of accumulating unfolded proteins is sensed and UPR activation 
is initiated by the Ire1p ER lumenal domain, Ire1p’s dimerization (or oligomerization) is 
triggered across the ER membrane (See the figure on page 24). This results in optimal 
and close positioning of Ire1p Ser/Thr kinase domains in the cytoplasm. These domains 
are then autophosphorylated in trans, which is supported both by intragenic 
complementation analysis between some IRE1 alleles and direct physical interactions 
among the cytosolic regions (Shamu and Walter, 1996; Welihinda and Kaufman, 1996). 
For example, in budding yeast, an ire1 allele missing the C-terminal tail, still maintains 
kinase activity but not endonuclease activity, and it is able to complement the UPR 
activity of an ire1 kinase-dead allele, still having intact C-terminal tail and endonuclease 
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activity. Such intragenic complementation also provides strong evidence for 
dimerization or oligomeriztion of Ire1p during the UPR. The autophosphorylation 
primarily happens on S840 and S841. Although in vitro data also show that T844 is 
phosphorylated, its physiological significance is unclear. In contrast, the dual 
phosphorylations at S840 and S841 are absolutely required for normal function of the 
UPR signaling pathway in vivo. In budding yeast, when both of Serines are substituted 
into Alanines, making non-phosphorylatable variants, UPR signaling is essentially 
eliminated. The mutant is very sick under ER stress and phenotypically behaves like an 
ire1 null (Guo and Polymenis, 2006; Shamu and Walter, 1996). Therefore, 
phosphorylation is critical for the physiological function of the IRE1-mediated UPR; it 
also potentially provides a way to down-regulate UPR activity in vivo. 
Dual phosphorylation at S840 and S841 is believed to lead to a conformational 
change of Ire1p’s cytosolic domain, which further activates the C-terminal tail’s 
endoribonuclease activity towards its sole substrate, the HAC1 mRNA (Niwa et al., 2005; 
Sidrauski and Walter, 1997) (See the figure on page 24). The conformational change of 
IRE1 cytosolic domain and activation of its C-terminal tail nuclease activity can also be 
achieved through association of small molecules. For instance: in vitro, adenosine 5’-
diphosphate (ADP) or nonhydrolyzable ATP analog (AMP-PNP) can activate Ire1p* 
(the recombinant cytosolic portion of Ire1p), but not guanosine 5’-triphosphate (GTP) 
(Sidrauski and Walter, 1997); more interestingly, in vivo, the ATP-competitive drug 1-
tertbutyl-3-naphthalen-1-ylmethyl-1H-yrazolo[3,4-d]pyrimidin-4-ylemine (1NM-PP1) 
can restore UPR activity of the Ire1 kinase-dead variant—Ire1p (L745G) (which only 
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has ~10% UPR activity). The replacement of Leu745—located at a conserved position in 
the adenosine 5’-triphosphate (ATP)–binding site—to Ala or Gly is predicted to 
sensitize Ire1p to the 1NM-PP1 by creating an enlarged active-site pocket (Bishop et al., 
1998; Papa et al., 2003). Regardless of how it can be activated, all the data indicate that 
the C-terminal tail nuclease activity is directly under the control of the Ire1p cytosolic 
kinase domain. Finally, given the low or zero UPR activity of non-phosphorylatable and 
kinase dead variants of Ire1p, the phosphorylation event must be required for the normal 
function of IRE1-mediated UPR signaling pathway in vivo. 
Overall, upon ER stress, the three functional domains of Ire1p are activated 
sequentially across the ER membrane after initiation inside the ER lumen. In other 
words, IRE1 itself is both a primary sensor and a transducer, playing dual roles in the 
UPR signaling pathway (See the figure on page 24). Consequently, modulating IRE1 
activity would have a direct impact on the UPR, generating the most effective way to 
manipulate the UPR. 
 
HAC1 UNCONVENTIONAL SPLICING AND TRANSLATIONAL CONTROL 
Hac1p was first identified as a basic leucine Zipper (bZIP) transcription factor 
homologous to Atf/Creb1 (Nojima et al., 1994). At about the same time, HAC1 was 
found in two screens for high copy suppressors of the inositol auxotrophic phenotype of 
the ire1 mutation that restore UPR activity of ire1 mutants, which also indicate that 
HAC1 may function downstream of IRE1 (Cox and Walter, 1996; Nikawa et al., 1996). 
Interestingly, Hac1p protein was only detected in UPR-on cells, while its mRNAs were 
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present in both UPR-on and UPR-off cells at comparable levels (Cox and Walter, 1996; 
Kawahara et al., 1997). These HAC1 mRNAs are respectively named as HAC1u (“u” for 
uninduced , UPR-off state) and HAC1i (“i” for induced, UPR-on state) mRNA. 
Consequently, the proteins encoded by these two forms of HAC1 mRNA are called 
Hac1pu and Hac1pi, respectively. The HAC1i mRNA is formed by the removal of a 252 
base pair intron from the HAC1u mRNA by a non-conventional splicing mechanism, 
because the splicing process is spliceosome-independent but Ire1p-dependent. Activated 
ER transmembrane kinase/endonuclease Ire1p can specifically cleave both 5’- and 3’-
exon-intron junctions in HAC1u mRNA (Sidrauski and Walter, 1997). The 5’- and 3’- 
portions of the mRNA are re-joined by the tRNA ligase, Rlg1p. An rlg1 temperature 
sensitive mutant is totally defective in UPR and splicing of HAC1 mRNA (Sidrauski et 
al., 1996) (See the figure on page 24).  
Three lines of evidence indicate that the expression of Hac1p is essentially 
controlled at the translation level. First, HAC1u mRNA is primarily detected in the 
cytoplasm (Chapman and Walter, 1997), thus ruling out that HAC1u mRNA is retained 
in the nucleus. Second, a large portion of HAC1u mRNA co-migrates with 
polyribosomes in sucrose gradients and can be immunoprecipitated with an antibody 
against an N-terminal epitope, demonstrating that the N terminus of the protein is made 
and exposed outside the ribosome (Chapman and Walter, 1997; Cox and Walter, 1996); 
These results also suggest that translation of Hac1pu is initiated, but those ribosomes 
then stall on the mRNA before translation is completed. Third, the Hac1pu produced by 
intronless constructs has a similar half-life of Hac1pi in yeast cells (t1/2 ~2 min) 
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(Chapman and Walter, 1997; Kawahara et al., 1997), suggesting that fast protein 
degradation is unlikely. Because HAC1u mRNA is barely translated but HAC1i mRNA is 
translated promptly and efficiently after splicing, the spliced intron may play a key role 
in limiting translation of HAC1u mRNA. Indeed, further studies demonstrate that the 
intron region of HAC1u mRNA not only forms stem-loop-like secondary structure itself 
but also bends towards its 5-UTR region with base-pairing interactions (See the figure 
on page 24). Thus, the intron and the 5’-UTR need to work together for blocking 
translation of HAC1u mRNA (Ruegsegger et al., 2001). These unique RNA structures 
prevent ribosomes from reading through after initiation of translation, stalling HAC1u 
mRNA in polyribosome state. Therefore, the only way to release the translational block 
of HAC1u mRNA is to remove its intron specifically by activated Ire1p. Also, because of 
how translation is blocked, the Hac1p protein is literally already “half made”. Thus, 
Hac1pi is produced rapidly upon the activation of Ire1p, which explains quite well why 
UPR can be turned on in a very short time, only taking about 10 minute after 
experimental induction in yeast (See the figure on page 24). 
Mutated X-box binding protein-1 (XBP-1), the mammalian counterpart of HAC1, 
was first shown to block the UPR in C. elegans. Activation of the UPR causes IRE1-
dependent splicing of a small intron from the XBP-1 mRNA both in C. elegans and 
mice. The protein encoded by the processed murine XBP-1 mRNA accumulated during 
the UPR, whereas the protein encoded by unprocessed mRNA did not (Calfon et al., 
2002; Shen et al., 2001). So far, HAC1 or XBP-1, are the only substrates of yeast Ire1p 
or human Ire1p nuclease, respectively (Calfon et al., 2002; Cox and Walter, 1996; Niwa 
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et al., 2005). Both splicing events are induced by the activation of Ire1p in responding to 
the accumulation of unfolded proteins in the ER lumen (Bertolotti et al., 2000; Cox et 
al., 1993; Shamu and Walter, 1996).  
 
HAC1-MEDIATED UPR TARGET GENES 
Hac1pu and Hac1pi are identical except for their C-terminal tails. Splicing 
replaces a tail of 10 amino acids encoded in the intron of HAC1u mRNA with a tail of 18 
amino acids encoded in the second exon of HAC1i mRNA. Therefore, removal of the 
HAC1 intron not only allows translation of the mRNA but also alters the sequence and 
properties of the encoded protein. The DNA-binding domain in the N-terminal 220 
amino acids common to Hac1pi and Hac1pu is undisturbed during the splicing, but the C-
terminal trans-activation domain is altered. The C-terminal tail of Hac1pi served as a 
very highly active transcriptional activation domain, while the Hac1pu tail was 
essentially inactive, after fusing them to an unrelated DNA-binding domain (Kawahara 
et al., 1997; Mori et al., 2000). Thus, splicing also results in a stronger transcription 
factor, Hac1pi (Figure 1.1). 
Hac1pi is responsible for activating transcription of a large set of UPR target 
genes in yeast (~5% of the genome). The majority of them encode gene products 
involved in protein folding, such as KAR2 and PDI; ER-associated protein degradation 
(ERAD) components, such as DER1and HRD3; and many proteins that function 
downstream in the secretory pathway (Travers et al., 2000). This large set of up-
regulated genes fits well with the goal of the UPR signaling pathway to cope with ER 
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stress. Although Hac1pi expression is sufficient for induction of several ER target genes, 
Hac1pi also needs to recruit some or all of the components of the SAGA complex, a 
multiprotein assembly involved in histone acetylation during transcriptional activation, 
to the promoters of UPR target genes; this interaction is necessary for full induction of a 
subset of targets (Welihinda et al., 1997). Interestingly, one component of the SAGA 
complex, Ada5p, appears to interact with the cytosolic domain of Ire1p and be required 
in vivo for the splicing of HAC1 mRNA (Welihinda et al., 2000). Additionally, HAC1 
mRNA transcription is also regulated through an Ire1p-independent pathway, adding 
more levels of complexity in UPR signaling (Patil et al., 2004). 
So far, three cis-acting promoter elements regulated by Hac1p have been 
identified. They are: (1) the unfolded protein response element (UPRE, CAGNGTG) 
(Mori et al., 1992). It is the major regulatory element of Hac1p, found in the promoters 
of ER chaperone genes; most of UPR target genes have UPRE on their promoters, but 
some ER-associated protein degradation genes are regulated by Hac1p in a UPRE-
independent manner. Mammalian UPR target genes also carry consensus promoter 
sequence, called ER stress-response element (ERSE, CCAATN9CCACG), which are 
regulated by XBP-1 and ATF6 (Yoshida et al., 1998). (2) subtelomeric ATF/CREB GTA 
variant element (SACE, ATGGTATCAT) (Spode et al., 2002); (3) the upstream 
repressing sequence 1 (URS1, TCGGCGGCT), found in the promoters of early meiotic 
genes and many genes involved in carbon and nitrogen utilization; it makes Hac1pi the 
first bZIP transcription factor in yeast that both activates and represses transcription 
(Schroder et al., 2004). 
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Figure 1.1 The unfolded protein response signaling pathway in Saccharomyces cerevisiae 
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UPR IS ANTI-MITOGENIC 
It has been known since the 1980s that tunicamycin, an inhibitor of protein N-
glycosylation that also induces the UPR, would eventually cause cell-cycle arrest in both 
yeast and human lymphoma cells. This occurred in the G1 to S transition and blocked 
DNA synthesis (Arnold and Tanner, 1982; Nishikawa et al., 1980; Savage and Baur, 
1983). In yeast, constitutive expression of the intron-less HAC1i transcript significantly 
delays cell proliferation (Kawahara et al., 1997). It might be partially explained by the 
association of Hac1pi with the URS1 primary transcriptional repressor Ume6p, a 
Zn2Cys6 cluster protein. Ume6p can cause the repression of ~10% to ~20% of all yeast 
genes; the majority of them are involved in metabolism, such as carbon and nitrogen 
utilization (Strich et al., 1994). 
In mammalian cells, there is clear evidence that experimental induction of the 
UPR in mouse NIH 3T3 fibroblasts with tunicamycin leads to a decline in cyclin D- and 
E-dependent kinase activities and to G1 phase arrest (Brewer et al., 1999). The loss of 
cyclin D1 appears to be directly mediated by the kinase activity of PERK upon 
activation of UPR (Brewer and Diehl, 2000). Furthermore, sustained activation of the 
UPR could eventually trigger programmed cell death (Apoptosis), and all three known 
UPR signaling pathways may be directly involved (Wu and Kaufman, 2006). For 
example, activated Ire1p binds to the c-Jun-N-terminal inhibitory kinase (JIK) and 
recruits TRAF2 (TNF receptor-associated factor-2), which leads to the activation of 
ASK1 (apoptosis signal-regulating kinase 1)/JNK (c-Jun amino terminal kinase), and 
also to the release of the procaspase-12 from the ER, activating the caspase cascade 
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(Nakagawa et al., 2000; Nishitoh et al., 2002). CHOP (CEBP homologous protein), one 
of the UPR downstream effectors activated by both PERK/eIF2α/ATF4 and AFT6, 
inhibits the expression of Bcl-2 and thus promotes mitochondria-dependent apoptosis 
(Ma et al., 2002). 
Overall, the UPR is anti-mitogenic and pro-apoptotic. Due to the ultimate 
deleterious effects to growing cells, mechanisms that down-regulate the UPR must exist. 
However, compared to what is known about how the UPR can be activated and turned 
on, very little is known about how it can be down-regulated and turned off. There is only 
in vitro evidence that the Ptc2p phosphatase might be an Ire1p phosphatase in budding 
yeast (Welihinda et al., 1998), but there is no functional in vivo interactions between 
Ire1p and a phosphatase. 
Interestingly, in our genetic screen to further explore the physiological function 
of the Dcr2p phosphatase, among 12 genes obtained from the screen, 9 genes have 
putative roles in protein trafficking. These 9 genes are RIC1, YPT6, SWA2, VPS54, TFP1, 
VPS51, SFH1, IRE1, PTC1 (Chapter IV). Protein trafficking defects trigger the UPR 
(Patil and Walter, 2001). Both RIC1 and YPT6 were already known to have genetic 
interactions with DCR2. Ric1p acts as a GTP exchange factor for the Ypt6p GTPase, 
regulating intracellular trafficking (Siniossoglou et al., 2000). SWA2 and VPS54 are 
likely UPR target genes because of their fairly good expression pattern correlation value 
to the known UPR target genes, 0.944 and 0.965 respectively (Travers et al., 2000). 
Finally, we demonstrated that ire1 is synthetically lethal with dcr2; the Dcr2p 
phosphatase de-phosphorylates Ire1p in vitro, and interacts physically with Ire1p in vivo, 
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and down-regulates the unfolded protein response in Saccharomyces cerevisiae (Chapter 
IV). 
 
UPR MODULATION IS NECESSARY 
The UPR signaling pathway is an elaborate mechanism to ensure that only 
properly folded and assembled proteins exit the ER, a process termed "quality control." 
Increasing evidence indicates that the UPR needs to be activated even in cells considered 
healthy or unstressed due to variable internal environments. For example, the UPR 
signaling pathway is required in cells with defective ER-associated degradation (ERAD) 
in yeast and mammalian cells (Hori et al., 2004; Lee et al., 2003; Travers et al., 2000). 
UPR signaling in unstressed cells also appears to play a role in nutrition sensing and 
differentiation programs. The major molecular chaperones of the ER, BiP/GRP78 and 
GRP94, are induced by glucose starvation or anaerobiosis in mammalian cell 
(Pouyssegur et al., 1977), suggesting that the UPR is responsive to the nutritional state. 
Abrogation of PERK signaling through introduction of a Ser51Ala mutation into eIF2 
in mice resulted in hypoglycemia associated with defective gluconeogenesis and a loss 
of the pancreatic -cell population. The mice died within 18 hr after birth, which 
indicates that intact UPR signaling is critical for in vivo glucose homeostasis (Scheuner 
et al., 2001). During terminal differentiation of B cells into antibody-secreting plasma 
cells, XBP-1 is required and splicing of XBP-1 mRNA was observed (Calfon et al., 
2002; Iwakoshi et al., 2003; Reimold et al., 2001). 
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Furthermore, in yeast, the level of UPR activation in unstressed cells is tightly 
linked to the metabolic state of the cell. A low level of HAC1 splicing is observed in 
exponentially growing yeast in nitrogen-rich media (Schroder et al., 2000). Depending 
on carbon sources, between 3% and 30% of HAC1 mRNA were detected in term to total 
HAC1 mRNA. It is low on preferred, fermentable carbon sources (D-glucose and D-
fructose), intermediate on disaccharides (D-maltose), and high on nonfermentable 
carbon sources, (acetate or ethanol). In addition, upon nitrogen starvation, the UPR can 
be turned off quickly in less than 5min. On the other hand, upon ER stress induced by 
tunicanmycin, splicing of HAC1 can be sustained for more than 3 hours after the stress is 
removed (Chapter IV). It suggests that the UPR signaling pathway must be modulated in 
a subtle manner. It is possible that, depending on what signal is sensed, the UPR could 
be either activated in an unstable UPR-on/off status, likely involving in nutrient sensing 
or differentiation, or a stable UPR-on status, likely dealing with ER stress and even 
triggering apoptosis. Overall, UPR modulation is also necessary for “unstressed” cells, 
in addition to the stressed conditions. 
However, how UPR can be modulated is still mysterious, since very little is 
known about how to turn it off. We obtained clear evidence, both in vitro and in vivo, 
that Dcr2p attenuated the UPR by directly targeting Ire1p in budding yeast (Chapter IV). 
Given that both gain- and loss-of-function DCR2 alleles sensitized cells to tunicamycin; 
over-expression of DCR2 could significantly delay HAC1 splicing, but not block it; and 
Dcr2p is modified under ER stress in a time-dependent fashion, Dcr2p might work as a 
UPR modulator, possibly required for both off- and continuous on-state of UPR. 
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The pathogenic roles of the UPR are steadily drawing more and more attention. 
Viral infections activate the UPR (Tardif et al., 2005), and rapidly growing cancer cells 
rely on the UPR for their survival (Reimold et al., 1996). To understand more about how 
the UPR can be turned off would extend our knowledge about all these important 
cellular events, and potentially lead to the development of antiviral or chemotherapeutic 
cancer agents. 
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CHAPTER II 
MATERIALS AND METHODS 
 
Cell cultivation, media preparation and yeast molecular biology techniques were 
performed as described by Kaiser et al (Kaiser et al., 1994), unless otherwise indicated. 
 
STRAINS AND DNAs 
The Saccharomyces cerevisiae standard strains were obtained from the Yeast 
Genetic Stock Center, Calif., USA, others were generated from these standard strain 
genetic backgrounds in our lab for particular purposes. Most of the strains used in this 
study are listed in Table 2.1. 
The IRE1-S840A/S841A and IRE1-S840E/S841E strains were generated by 
transformation of the wild type strains (BY4741 and BY4742) with the PCR-products 
bearing the two amino acid mutations and marked by the HIS3 gene (Kaiser et al., 1994). 
The PCR-products were generated by amplification of plasmid PGALl-IRE1-TAG with the 
following oligonucleotide primers respectively: 
S840A/S841A Forward 5’-
AATTTTGATATCAGACTTTGGTCTTTGCAAAAAACTAGACTCTGGTCAGGCT
GCATTTAGAACAAATTTGAATAACCCTTC–3’,  
S840E/S841E Forward 5’- 
AATTTTGATATCAGACTTTGGTCTTTGCAAAAAACTAGACTCTGGTCAGGAG
GAATTTAGAACAAATTTGAATAACCCTTC-3’. 
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Ire1(+3516) Reverse 5’-GTCTGTCGGGTAGTTTATGTAGGGATG-3’ 
 
 
 
Table 2.1 Saccharomyces cerevisiae strains and their relevant genotypes 
Strain Relevant genotype Source 
BY4741 MATa his3 leu2 met15 ura3 Res. Genetics 
BY4742 MAT his3 leu2 met15 ura3 Res. Genetics 
BY4743 BY4741/BY4742 Res. Genetics 
W303a MATa ade2 trp1 leu2 his3 ura3 can1 B. Futcher 
X2180-5B MATa SUC2 mal mel gal2 CUP1 ATCC 
ire1∆ ire1 ::kanMX (BY4742 otherwise) Res Genetics 
SCMSP59 PGAL-SIK1::HIS3 (BY4741 otherwise) (Bogomolnaya et al., 2004a) 
ABXL-1D MATa, FLO1, gal1 Res. Genetics 
SCMSP49 Ura– derivative of ABXL-1D (Bogomolnaya et al., 2004a) 
SCMSP87 PGAL-HYM1::his3MX/HYM1+ (BY4743 otherwise) (Bogomolnaya et al., 2004b) 
LBY1 Hym1∆::his3MX (W303 otherwise) (Bogomolnaya et al., 2004b) 
SCMSP67 cln3∆::URA3 hym1∆::his3MX (W303 otherwise) (Bogomolnaya et al., 2004b) 
SCMSP63 PGAL-ACE2::his3MX (W303 otherwise) (Bogomolnaya et al., 2004b) 
SCMSP114 PGAL-ACE2::his3MX cln3∆ URA3 hym1∆
LEU2 (W303 otherwise) 
(Bogomolnaya et al., 2004b) 
SCMSP86 PGAL-ACE2::his3MX cln3∆::URA3 (W303 
otherwise) 
(Bogomolnaya et al., 2004b) 
SCMSP73 PGAL-ACE2::his3MX hym1∆::LEU2 (W303 
otherwise) 
(Bogomolnaya et al., 2004b) 
LBY1(PGAL-CLN3) hym1∆::his3MX [PGAL-CLN3-CEN URA3] (W303 
otherwise) 
(Bogomolnaya et al., 2004b) 
W303(PGAL-CLN3) [PGAL-CLN3-CEN URA3] (W303 otherwise) (Bogomolnaya et al., 2004b) 
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Table 2.1 (Continued) 
Strain Relevant genotype Source 
SCMSP74 P GAL –KEM1::his3MX (BY4741 otherwise)  (Pathak et al., 2005) 
SCMSP81 P GAL –KEM1::his3MX/KEM1 + (BY4743 
otherwise)  
(Pathak et al., 2005) 
4540 kem1::kanMX (BY4741 otherwise)  Res. Genetics 
SCMSP75 PGAL-GID8::his3MX/GID8+ (BY4743 otherwise) (Pathak et al., 2004) 
SCMSP76 PGAL-DCR2::his3MX/DCR2+ (BY4743 otherwise) (Pathak et al., 2004) 
RPY3 PGAL-DCR2::his3MX (BY4741 otherwise) (Pathak et al., 2004) 
SCMSP112 gid8∆::URA3 dcr2∆::his3MX (BY4741 otherwise) (Pathak et al., 2004) 
6576 gid8 ::kanMX (BY4741 otherwise) Res. Genetics 
RPY1 dcr2 ::his3MX (BY4741 otherwise) (Pathak et al., 2004) 
SCMSP116 gid8 ::URA3 (BY4741 otherwise) (Pathak et al., 2004) 
SCMSP131 cln3 ::kanMX gid8 ::URA3 dcr2 ::his3MX 
(BY4741 otherwise) 
(Pathak et al., 2004) 
SCMSP123 cln3 ::kanMX gid8 ::URA3 (BY4741 
otherwise) 
(Pathak et al., 2004) 
10366 cln3 ::kanMX (BY4742 otherwise) Res Genetics 
ptc1 ptc1 ::kanMX (BY4742 otherwise) Res Genetics 
ire1S840A/S841A IRE1-S840A/S840A His (BY4741 otherwise) (Guo and Polymenis, 2006) 
ire1S840E/S841E IRE1-S840E/S841E His (BY4741 otherwise) (Guo and Polymenis, 2006) 
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The plasmid was list in Table 2.2. The pET-28a(+)-Ire1* was a gift from Peter 
Walter (Papa et al., 2003). Ire1* is cytosolic portion of Ire1 with fully functional kinase 
and endonuclease domain. The plasmid PGAL1-DCR2DN was generated through co-
transformation and recombination in wild type strain (BY4743) with linearized plasmid 
2µ DCR2DN cut by restriction endonuclease and PCR-product of amplification from 
genomic DNA of pGAL1-DCR2 strain by the following oligonucleotide primers: 
DCR2-(+1213)-Forward: 5’-CGGTTGGTAAAATTTATCCTGG-3’ 
DCR2-(+2223)-Reverse: 5’-CTGATGTCGCAGGACGAGTC-3’ 
The plasmid was finally sequenced to verify the introduced mutation and the absence of 
any other mutations at the Genome Technologies Laboratory of Texas A&M University. 
 
 
 
Table 2.2 Plasmids and their relevant characteristics 
Plasmid Relevant characteristic Source 
DCR2 2 [DCR2] URA3 (Pathak et al., 2004) 
DCR2DN 2 [DCR2DN] URA3 (Pathak et al., 2004) 
pBAD-DCR2 [PBAD-DCR2-TAG] URA3 This study 
pBAD-DCR2DN [PBAD- DCR2DN-TAG] URA3 This study 
BG1805-DCR2 2 [PGAL1-DCR2-TAG] URA3 Open Biosystems 
BG1805-IRE1 2 [PGAL1- IRE1-TAG] URA3 Open Biosystems 
pGAL1-DCR2DN 2 [PGAL1-DCR2DN] URA3 This study 
PET-28a(+)-Ire1* [PT7-Ire1*-6XHis] Amp P Walter 
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MICROSCOPY AND FLOW CYTOMETRY 
For microscopic examination of nuclear morphology, the cells from each 
indicated growth rates of either nitrogen or glucose limitation chemostats were stained 
with DAPI, 4',6-diamidino-2-phenylindole, from Molecular Probes (Ore.). The protocols 
we followed are from the Botstein laboratory, as described at http://genome-
www.stanford.edu/group/botlab/protocols.htm. The stained cells were examined under a 
UV filter for nuclear morphology. Lastly, the evaluation of cell cycle progression is 
based on bud size and nuclear morphology as described previously (Bogomolnaya et al., 
2004a). 
DNA contents were obtained by flow cytometry as described previously (Haase 
and Lew, 1997), except that cells were stained with Sytox green (1 mM; Molecular 
Probes, Ore., USA) instead of propidium iodide. This resulted in higher quality DNA 
content profiles, in which the G1 and G2/M histogram peaks were sharp and well 
separated (see the figure on page 50), allowing for more accurate quantitative 
measurements. To generate the DNA content histograms, the same number of cells 
(30,000) was collected for any given growth rate and nutrient limitation, and the 
percentage of cells in G1 (indicative of the length of the G1 phase) was calculated from 
the DNA histograms using the ModFit software (Verity Software House, Me., USA). 
Although estimates of S phase duration (rigorously defined as the interval between the 
earliest and latest events of DNA synthesis from origins of DNA replication) were 
obtained, they are not reported because it is thought that flow cytometry may under-
represent the actual duration of S phase (Haase and Lew, 1997). Note also that it was not 
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possible to distinguish G2 from M phase cells based on flow cytometry data. These 
considerations, however, did not impact on the objective of this study, because the 
duration of non-G1 phases (S, G2, M) were collectively compared to that of G1. 
Briefly, the procedure for flow cytometry analysis of DNA content is the 
following: cells (1x107 cells/ml) were fixed overnight in an Ethanol-PBS solution 
(mixed at a 7:3 ratio); they were then re-suspended in 50 mM sodium citrate buffer (pH 
7.0). The sample was treated with RNaseA (0.25 mg/ml) overnight at 37 °C. Finally, the 
sample was re-suspended in a 50 mM sodium citrate buffer (pH 7.0) containing 1 mM 
Sytox Green and sonicated for 10 seconds, immeadiately before it was evaluated by flow 
cytometry. 
 
CHEMOSTAT AND NUTRIENT LIMITATION MEDIA 
Chemostat conditions were similar to those reported previously (Baganz et al. 
1997). A VirTis (Gardiner, N.Y., USA) chemostat with a 600-ml working volume was 
used. Temperature (30°C), airflow (2 l/min), stirring speed (300 rpm) and pH (5.5) 
remained constant in all experiments. The filtered minimal media contained 1.7 g yeast 
nitrogen base (without amino acids and ammonium sulfate)/l (Difco, Mich., USA). 
Glucose-limited media had 0.8 g dextrose/l (Quality Biosources, Tx., USA) and 5 g 
ammonium sulfate/l (Fisher Scientific). Nitrogen-limited media had 20 g dextrose/l and 
0.5 g ammonium sulfate/l. No sample was taken from the chemostat for further analysis 
unless the cells were cultured for at least five generations at any given dilution rate. 
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Viability of samples taken from the chemostats was evaluated on solid rich media, 
containing 10 g yeast extract/l, 20 g peptone/l and 20 g dextrose/l. 
Cell cycle progression was evaluated in chemostats in which the growth, or 
dilution (D), rate can be altered separately from nutrient-dependent variables simply by 
altering the speed of the pump that introduces fresh medium in the culture. The reasons 
are the following: A chemostat is a completely mixed continuous stirred-tank reactor 
(CSTR), in which the medium is pumped continuously and the volume is constant since 
the excess medium overflows, so the conditions in the reactor do not change with time. 
Therefore, when equilibrium is established inside the reactor, the rate of production of 
cells equals to the rate of loss of cells though overflow (K*X=D*X, so K=D, K is 
growth rate, D is dilution rate). In other words, a chemostat can be used to run the 
reactor at particular growth rate by controlling the feed rate into the reactor. (Book, 
“Physiology of the Bacterial Cell: A Molecular Approach” by Frederick C. Neidhardt, 
John L. Ingraham, Moselio Schaechter; Sinauer Associates Inc, June 1990). 
 
CELL SIZE MEASUREMENT 
Cell size was measured using a Beckman Coulter Z2 Channelyzer. Each time the 
Channelyzer needs to be flushed three times before use. The samples were sonicated to 
disperse clumps prior to analysis, which was further confirmed by microscopic 
examination. The data were analyzed using the manufacturer’s AccuComp software. The 
reported values are based on the geometric mean of the cell size distribution of each 
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sample. Besides the cell size, the Channelyzer also gives the cell density at the same 
time. 
 
BUDDING INDEX AND DOUBLING TIME MEASUREMENTS 
The percentage of budded cells (budding index) was evaluated as described 
elsewhere (Zettel et al., 2003). Because of the unique feature of budding yeast that the 
appearance of a bud is concomitant with completion of START, the percentage of 
unbudded cells corresponds to the relative duration of G1 phase and the percentage of 
budded cells equals to non-G1 phase when the overall doubling time is the same. The 
budding index is the fraction of budded cells in a population. In this sense, for equal 
overall doubling times, a high budding index is indicative of a shorter G1 phase, so cell 
cycle progression is accelerated; low budding index is indicative of a longer G1 phase, 
so cell cycle progression is delayed. Budding index usually expressed as relative values, 
compared to its control strain (usually wild type strain) at any given time. 
Briefly, one needs to grow at least 20 inoculations of one strain into exponential 
phase, reaching at least 106 cells/ml, then count budded cells microscopically with a 
hemacytometer, in order to calculate the budding index and do statistics. 
There are two ways to measure the population doubling (generation) time in 
these studies. One is to use the absorbance at 595nm (A) obtained with a 
spectrophotometer at multiple time points (t) during the exponential growth of the 
culture, which is particularly useful for strains with a segregation defect strain, such as 
hym1. The other one is to use the Beckman Coulter® counter Channelyzer to measure 
  38 
 
the cell density at multiple time points (t) during the exponential growth of the culture. 
These values can be plotted against time (t), to obtain both the slope (k) and linear 
regression value (R2) of the line. When R2 is between 1 and 0.9, the k is taken. The 
culture’s doubling time (g) is then calculated from the formula g = ln2/k. For each 
particular strain, doubling times were measured at least three times. 
These two experiments, budding index and doubling time, were done for all the 
strains studied in these papers (Bogomolnaya et al., 2004a; Bogomolnaya et al., 2004b; 
Bogomolnaya et al., 2006; Pathak et al., 2004; Pathak et al., 2005). 
 
IMMUNOFLUORESCENCE MICROSCOPY 
For the subcellular localization of Gid8p and Dcr2p in the paper (Pathak et al., 
2004), we used cells expressing alone epitope-tagged Gid8p-HA, Dcr2p-Myc, or co-
expressing Gid8p-HA and Dcr2p-Myc, and two untagged controls (BY4742 for the HA-
tagged strains or BY4741 for the Myc-tagged strains, BY4743 for the co-expressing 
strain). Cells were grown into mid-log phase in 5 ml YPD. We then add 0.5 ml 37% 
formaldehyde and incubated at 30°C for 1h. The cells were centrifuged and resuspended 
in Sorbitol Buffer (0.5ml 40mM KPO4 (pH6.5), 500µM MgCl2, 1.2M Sorbitol). We then 
added 100 µl of a 3 mg/ml Zymolyase (20T) solution, and incubated for 30~45 min at 
30°C. The cells were then washed once with Sorbitol Buffer, then resuspended in 
100~500 µl Sorbitol Buffer. A 25µl cell suspension were then spotted on a polylysine-
coated slide and incubated at room temperature for 10 min. The slide was plunged into a 
container with ice-cold methanol for 6 min, then plunged into another container with ice-
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cold acetone for 30 sec. The slide was then immediately placed against a slanted, flat, 
warm, clean surface so that the acetone could evaporate without the creation of 
condensation. The slides were then blocked in PBS pH 7.4 with 1% BSA Tween 20 for 
15min at room temperature. The cells were incubated in primary antibody at the 
appropriate dilution in block solution for 1h at RT; washed 4 times for 5min per time; 
incubated in secondary antibody conjugate (either FITC or TRITC) diluted in block 
solution for 1h at RT. The slides were washed again and mount solution was added 
(100mg p-phenylenediamine in 10ml PBS, add volume to 100 mls with glycerol 
pH=8.0) with 50ng/ml DAPI. 
Immunofluorescence microscopy followed the protocols of the Botstein lab as 
described at http://genome-www.stanford.edu/group/botlab/. The samples were 
examined with a Nikon Eclipse TS100 inverted fluorescence microscope. 
 
BACTERIAL EXPRESSION 
The pBAD-DCR2-TAG, and pET-28(a)-IRE1*, plasmids were transformed into 
E. coli XL1-Blue, and BL21, respectively. For protein expression we followed 
previously published procedures (Guzman et al., 1995; Nock et al., 2001). Briefly, five 
or six colonies were used to start a 50 ml preculture in Luria-Bertani (LB) medium, 
containing either 50µg/ml Ampicillin (for pBAD-DCR2-TAG) or 100µg/ml Kanamycin 
(for pET-28(a)-IRE1*). The precultures were grown for 14h to late log phase and used to 
inoculate larger batches at a dilution of 1:200 in LB medium. The larger batch volume 
we used was 1L, shaking flasks (225 rpm) at 37°C to an OD600 of 0.6 to 0.8. For the 
  40 
 
pBAD cultures, we induced with 1% Arabinose sitting on the bench overnight at RT. For 
the pET-28(a)-IRE1* cultures, we induced with 0.7mM isopropyl-β-D-
thiogalactopyranoside (IPTG) at 30°C for 4h. After induction, the cultures were placed 
in the cold room (4°C) overnight. Lastly, cells were harvested by centrifugation with a 
GSA rotor at 16,000g at 4°C for 15min, and stored in -80°C for cell lysis by french press. 
 
FRENCH PRESS LYSIS 
The 1L cell pellet were resuspended in 15ml Buffer A (20 mM HEPES pH7.5, 
150 mM KCl, 1 mM dithiothreitol (DTT), 5mM MgCl2, 10% (v/v) glycerol) containing 
complete Mini, EDTA-free protease inhibitor cocktail tablets (Roche Diagnostics) 
(Nock et al., 2001). All the components of the french press (outlet valve, lid, plunger and 
cell) were cooled down. A spot of glycerol was applied onto the rubber seals, then the 
plunger and lid were placed into the cell, and the outlet valve was fitted. It was then left 
open and the cells were loaded into the press cell. The cell was placed into the press, the 
clamp across the cell was closed to lock it in place and the two screws were tightened by 
finger. The press was turned on and the pressure increased to around 1400pa on the dial. 
The selector was switched from low, middle and high. The cells rise up and then stopped 
with the top of the press and held on the right pressure and allowing the pressure to build 
up. The outlet valve was gently opened and the pressure was applied to crush the cells. 
The sample was then drawn up into the cell. The samples were collected (watch the cells 
pushed down and quickly switch to the low when reaching the stop mark). This was 
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repeated three times, and clear cell lysis was obtained. The samples were aliquoted (1ml 
into 1.5ml tubes), and stored at –80°C. 
 
In vitro AUTOPHOSPHORYLATION AND DE-PHOSPHORYLATION ASSAY 
Following expression and lysis by french press, both Ire1p* and Dcr2p were 
partially purified through TALON Co2+ affinity beads (BD Biosciences, CA). The 
Ire1p* underwent in vitro autophosphorylation, then de-phosphorylation by Dcr2p or λ-
phosphatase with or without phosphatase cocktail inhibitors (Sigma). 
The in vitro autophosphorylation of Ire1p* was done as described by Nock et al 
(Nock et al., 2001). Briefly, Ire1p* was eluted in elution buffer (150mM Imidazole, 
300mM NaCl, 50mM Sodium Phosphate). Kinase buffer was added (20mM HEPES (pH 
7.5), 10 mM magnesium acetate, 50mM potassium acetate, 1mM DTT), also containing 
ATP and Aprotinin (1ug/10ul reaction volume). The reactions were incubated at 30°C 
for 30 min. 
De-phosphorylation by either Dcr2p or λ-phosphatase was performed in λ-
phosphatase reaction buffer containing 2mM MnCl2 with or without phosphatase 
cocktail inhibitors I or II from Sigma, and followed by SDS-PAGE protein analysis. 
 
PHOSPHOPROTEIN DETECTION ASSAY 
The assay we used (from PIERCE) to detect phosphoproteins was non-
radioactive, and relied on chemical modification for the specific detection of 
phosphorylated proteins. The rationale is the following: PhosphoProbe-HRP is an iron 
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(Fe3+)-activated (or conjugated) derivative of horseradish peroxidase (HRP). 
PhosphoProbe-HRP exhibits two distinct binding specificities, one of which is phosphate 
(R-PO3)-specific. The other binding specificity is related to a carboxyl-containing 
binding motif that is common to most proteins and some peptides. This carboxyl motif 
binding specificity can be used in a total protein detection application. However, a novel 
treatment, reactive chemical blocking (RCB), is used to eliminate this carboxyl-binding 
motif, thus imparting exclusive specificity toward phosphate groups. PhosphoProbe-
HRP, in conjunction with RCB, is a universal phosphate detection probe. PhosphoProbe-
HRP has been optimized for direct detection of phosphoester molecules such as 
nucleotides or protein/peptides containing phosphoserine, phosphothreonine and 
phosphotyrosine. Basically, the reactive chemical blocking (RCB) uses 1-Ethyl-3-[3-
dimethylaminopropyl]carbodiimide hydrochloride (EDC or EDAC) and 
Ethylaminediamine dihydrochloride (EDA) to modify any carboxyl-group of the protein, 
consequently blocking its interaction with PhosphoProbe-HRP. 
EDC is a zero-length crosslinking agent used to couple carboxyl groups to 
primary amines. This crosslinker has been used in diverse applications such as forming 
amide bonds in peptide synthesis, attaching haptens to carrier proteins to form 
immunogens, labeling nucleic acids through 5’ phosphate groups and creating 
amine-reactive NHS-esters of biomolecules. EDC reacts with a carboxyl to form an 
amine-reactive O-acylisourea intermediate. If this intermediate does not encounter an 
amine, it will hydrolyze and regenerate the carboxyl group. However, if the amine donor 
EDA is added into the reaction, carboxylic acids would be covalently modified with 
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short compounds containing primary amines at either end to form stable amide linkages. 
This will block the carboxylates and form terminal amino groups. 
The procedure is the following: Transfer protein onto nitrocellulose. Include 
phosphorylated and non-phosphorylated samples for controls. Block the blot with 
blocking solution (1% BSA) for 1 hour at room temperature with shaking. Wash blot 
three times with 50 ml of Quench Buffer (0.1 M MES (2-[N-morpholino]ethanesulfonic 
acid), pH 5.0, 50 mM EDA) for 5 minutes each with shaking. Prepare RCB Buffer by 
adding EDC to a final concentration of 25 mM to the Quench/Wash Buffer. Prepare 
RCB Buffer immediately before use. Add 50 ml RCB Buffer and shake at room 
temperature for the optimal time (predetermined from time study). Rinse with 50 ml 
Quench Buffer followed by two 50 ml washes with Quench Buffer for 5 minutes each. 
Wash blot three times with 50 ml of Acetate Wash Buffer (0.1 M sodium acetate, 1.0 M 
NaCl; pH 5.0) for 5 minutes each with shaking. Prepare PhosphoProbe Working 
Solution by diluting to 5 g/ml in Acetate Wash Buffer with 0.05% Tween®-20 (a 1:200 
dilution of Surfact-Amps 20 results in a final Tween-20 concentration of 0.05%). 
Remove Acetate Wash Buffer and add PhosphoProbe™ Working Solution (Block 
buffer). Incubate for 1 hour at room temperature with shaking. Wash four times with 50 
ml Acetate Wash Buffer containing 0.05% Tween-20 for 5 minutes each with shaking. 
Check supernatant of final wash for “free HRP” activity by adding 100 l of the 
supernatant to 1 ml of Turbo TMB ELISA substrate. Blue color production within 5 
minutes indicates washing was insufficient and requires additional washes. Decant wash 
solution. Add SuperSignal® Working Solution and incubate without shaking at room 
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temperature for 5 minutes, then place into plastic sheet protector. Squeeze out excess 
liquid from the sheet protector by wiping with a paper towel. Ensure that no air bubbles 
are visible between the sheet protector and the nitrocellulose. Expose to film initially for 
1 minute and develop. Blot can be exposed again to film to obtain an optimal image. The 
same blot can subsequently be blotted with anti-6XHistidine antibody or PAP antibody, 
to evaluate protein levels of Ire1p* and Dcr2p, respectively. 
 
TCA PROTEIN PRECIPITATION 
6ml yeast cultures were grown to mid-log phase. The cells were collected by 
centrifugation, washed once with distilled water, resuspended in 300ul of 1.85M NaOH 
with 7% 2-mercaptoethanol and vortexed at high-speed for 1 min. Add 150µl cold 100% 
Trichloroacetic Acid (TCA) was added and the samples were left on ice for 5min. The 
cells were centrifuged for 10min at maximum-speed in a microfuge at 4°C. The pellet 
was washed with 400~500µl 1M Tris-base (un-pHed) and left on ice for 5min. Lastly, 
the pellet was resuspended in 150µl of 8M Urea Buffer, and stored at –80°C. 
 
PROTEIN ANALYSIS 
For co-immunoprecipitation, the cells were lysed using glass beads, and the lysis 
buffer contained 0.9% NP-40, to extract the transmembrane protein Ire1p. TALON Co2+ 
affinity beads (BD Biosciences, CA) were used to pull down the Dcr2p-TAG 
(PrA+HA+6XHis) according to their instructions. Briefly, 50µl TALON Co2+ beads 
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were added; the samples were rotated at 4°C for 2h; washed in extraction buffer for 2 or 
3 times; and resuspended in Laemmli buffer with 5% β-mercaptoethanol. 
The gels for SDS-PAGE (Laemmli, 1970) contained 8% of a 29:1 
acrylamide/bis-acrylamide solution, and transferred onto nitrocellulose. The blots were 
blocked in PBS containing 5% w/v dry non-fat milk and 0.1% v/v Tween-20. Between 
incubations the blots were washed three times 10 min each, in PBS.  
Protein A fusion proteins were detected with the Peroxidase-Anti-Peroxidase 
(PAP) soluble complex reagent from Sigma (St. Louis, MO). The blots were processed 
with chemiluminescent peroxidase reagents from Pierce (Rockford, IL). X-ray films 
were developed using a Konica QX-130A developer. 
 
PREPARATION OF YEAST RNA 
Yeast RNA is efficiently released by disrupting the cells using high-speed mixing 
in the presence of glass beads and denaturing agents. Proteins are removed by extraction 
with organic solvents and the RNA is recovered by ethanol precipitation and quantitated 
by measuring its absorbance at 260 nm. Briefly, approximately 2×108 cells were 
harvested in the mid-log phase, and resuspended in 300µl RNA buffer (0.5M NaCl, 
200nM Tris, pH 7.5, 10mM EDTA) and 300µl of 25:24:1 phenol/chloroform/isoamyl 
alcohol in the presence of 200µl chilled glass beads. They were then vortexed 
immediately for 2 min at the highest speed. After centrifugation, the aqueous layer was 
transferred to a clean tube. An equal volume of 25:24:1 phenol/chloroform/isoamyl 
alcohol was added, and the samples were vortexed for another 10 sec. After 
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centrifugation, the aqueous layer was collected, and 3 volumes of ice-cold 100% ethanol 
were added to it. After mixing, the samples were incubated at –20°C for 30 min, and 
centrifuged for 2min at 4°C. The supernatant was removed and the pellet was washed 
with ice-cold 70% ethanol. Lastly, the pellet was resuspended in 50µl DEPC-treated 
H2O. 
 
NORTHERN ANALYSIS AND RT-PCR 
The DNA probe for Northern analysis we used was generated through Biotin 
Random Prime Kit from PIERCE, from a PCR product corresponding to the gene of 
interest. The Northern was performed by North2South Chemiluminescent Hybridization 
and Detection kit from PIERCE. Briefly, the protocol instructions are the following: take 
the picture of the capillary semi-wet transfer RNA blots and cross-link the blot by UV. 
Pre-hybridize the blots in Hybridization buffer with rotation for at least 30 min at 65°C. 
Add the DNA Biotin-labeled probe and hybridize overnight at 45°C. Wash blots three 
times for 15~20 min per wash with 2X stringency wash buffer (1X buffer contains 
2XSSC/0.1% SDS). Add blocking buffer for 15 min at RT and add Streptavidin-HRP for 
another 15 min at RT. Wash the blots with 1X wash buffer four times for 5 min per 
wash. Add Substrate Equilibration Buffer for 5 min at RT. Lastly, add North2South 
Luminol/Enhancer Solution and Stable Peroxide Solution (1:1) for 5 min, expose and 
develop film. 
RT-PCR was performed by Invitrogen kit, according to their instructions, using 
SuperScript III Reverse Transcriptase and reverse primer for the first cDNA strand, then 
  47 
 
regular PCR reaction. Finally analyze through agarose gel electrophoresis and ethidium 
bromide staining to visualize the products. 
 
TETRAD ANALYSIS 
Diploid cells were washed once in 5 ml sterile water. The pellet was resuspended 
in 2.5 ml SPM buffer (2% potassium acetate), and incubate at room temperature for 5~7 
days for sporulation. The cells were examined microscopically for tetrads. 0.5 ml of the 
sporulation culture were centrifuged, washed in 1 ml water, and resuspended in 50 µl of 
zymolyase solution (0.5 mg/ml in 1M sorbitol). After an incubation for 8~10 min at 
30°C, 0.8 ml sterile water were slowly added to the tube, and placed on ice. 15µl were 
then plated on a YPD plate, for dissection using a dissection microscope. 
 
SERIAL DILUTION PLATING ASSAY 
For examining any growth defect of yeast strains with or without stress, cells 
were grown into mid-log phase, and the cell density was measured microscopically with 
a hemacytometer. We used 96-well plates to set up 10 fold serial dilutions, starting at 
5000 cells. These numbers of cells were spotted onto plates with a multiple channel 
pipette. 
 
HIGH THROUGH-PUT YEAST TRANSFORMATION 
We used 96 well plates to do transformation of thousands of yeast homozygous 
diploid knockout strains (~4,300 homozygous deletion strains) by one common plasmid. 
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The assay was modified from the multiwell transformation protocol used by the 
Saccharomyces Genome Deletion Project (http://www-
sequence.stanford.edu/group/yeast_deletion_project/).  
Briefly, we replicated the diploid knockout collection plate to a new plate 
containing 100µl YPD per well. The plates were incubated overnight, replicated again 
and incubated overnight at 30°C. The plates were centrifuged at 4000 rpm for 10 min. 
The media were poured onto a paper tissue inside the hood. We then added 5µl high 
quality purified plasmid (1~2µg DNA) and 5µl carrier DNA (Salmon Sperm DNA) and 
20µl 1X TE/LiAC buffer per well. The plates were incubated at 30°C for 30 min. 150µl 
1X TE/LiAC/PEG buffer were added and incubated at 30°C for 30 min. We then added 
17µl DMSO, and incubated the plates at 42°C for 15 min. We centrifuged the plates at 
4000 rpm for 5 min, removed the transformation mix onto paper tissue inside the hood, 
added 30µl YPD and incubated the plates at 30°C for 3hrs. Lastly, we spotted the exact 
layout as the deletion collection plates onto two kinds of 150mm large selective medium 
plates and incubated them at 30°C for 2~3 days. 
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CHAPTER III 
NUTRIENT-SPECIFIC EFFECTS IN THE COORDINATION OF 
CELL GROWTH WITH CELL DIVISION IN CONTINUOUS 
CULTURES OF Saccharomyces cerevisiae* 
 
INTRODUCTION 
When the growth of Saccharomyces cerevisiae cells is limited, it is thought that 
doubling time delays reflect a prolongation of the first gap phase (G1) of the cell cycle, 
before DNA replication (S phase). Passage through START, a nodal point in late G1 
where various aspects of the cell s physiology are monitored, is thought to ensure that 
growth requirements are met before the cell commits to the process of cell division 
(Pringle and Hartwell 1981). This general understanding of coordination between growth 
and division implies that growth control is nutrient-mediated but not nutrient-specific. In 
other words, as long as two different media compositions allow for the attainment of the 
same growth rate, the cell cycle profiles of proliferating cells in those two media should 
be identical. In S. cerevisiae, most of the experimental data seem to support the notion 
that all nutrient limitations exclusively prolong G1 and have very little effect on the  
__________________________ 
*Reprinted with permission from “Nutrient-specific effects in the coordination of cell 
growth with cell division in continuous cultures of saccharomyces cerevisiae” by Guo, 
J., Bryan, B. A., and Polymenis, M., (2004), Arch Microbiol 182, 326-330. Copyright 
2004 by Springer with kind permission of Springer Science and Business Media.
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Figure 3.1 Cell cycle progression at different growth rates and nutrient limitations. The cellular DNA 
content of Saccharomyces cerevisiae haploid strain BY4741 grown in chemostats at the indicated dilution 
rate and nutrient limitation was determined by flow cytometry. The y-axis represents the number of cells 
analyzed and the x-axis represents fluorescence per cell. The DNA content of cells in G1 and G2/M is 
indicated as 1C (the first peak) and 2C (the second peak), respectively. The DNA content panels shown 
are from Experiment 1 of Table 3.1. 
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other phases of the cell cycle (Pringle and Hartwell 1981). But in the vast majority of 
previous studies, alterations in growth rate were inseparable from nutrient-specific 
variables. To our knowledge, a comparison of cell cycle profiles, using accurate modern 
methodologies, in different nutrients and growth rates in continuous steady-state cultures 
is lacking. 
 
RESULTS 
Haploid strain BY4741 strain growing under either glucose or nitrogen limitation 
was examined at five different growth rates in each case, from 0.3 h–1 (2.31 h generation 
time) to 0.1 h–1 (6.93 h generation time). For each nutrient limitation two separate 
chemostat experiments were performed. At all growth rates and nutrient limitations, 
about 90% of cells were able to form colonies on solid media, suggesting that there were 
no growth rate or nutrient-specific effects on cell viability (data not shown).  
As glucose-limited cultures proliferated more slowly, the duration of the G1 
phase linearly increased from 43% (at D=0.3 h–1) to 63% (at D=0.1 h–1) of the total 
generation time (Figure 3.1, Table 3.1). In absolute terms this reflects a 4.4-fold increase 
(from 1 h to 4.4 h), even though the growth rate difference was 3-fold. The non-G1 
phases progressively expanded too, but to a lesser extent (from 1.3 h to 2.6 h; Figure 3.1, 
Table 3.1). It has been reported that in glucose-limited chemostats and for growth rates 
as low as 0.08 h–1 there is no increase in the duration of the cell cycle phases after 
initiation of DNA replication (Carter and Jagadish, 1978), and non-G1 phase expansion 
is detectable only at lower growth rates (Carter and Jagadish, 1978; Jagadish and Carter, 
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1977). The chemostat media used in these older studies contained much higher amounts 
of glucose (10 g/l) than in our study (0.8 g/l) and they were also complex, containing 
peptone and yeast extract (Carter and Jagadish, 1978; Jagadish and Carter, 1977; 
Johnston et al., 1979). We used minimal defined media (see above) to properly separate 
nutrient-specific from growth rate-specific variables. We also used different strains and 
in the older experiments (Carter and Jagadish, 1978; Jagadish and Carter, 1977; Johnston 
et al., 1979) chemostats were run at 24°C vs 30°C in our case. Perhaps more 
importantly, at the time of these older studies flow cytometry was not available and the 
duration of cell cycle phases was indirectly deduced using conditional cell division cycle 
(cdc) mutants, which require temperature and media changes (Jagadish and Carter 1977; 
Carter and Jagadish 1978; Pringle and Hartwell 1981). These experimental protocols 
perturb steady-state conditions of cell proliferation and introduce an additional level of 
uncertainty in the analysis and interpretation of the relevant data. It was later shown that 
these cdc strains are unreliable indicators of cell cycle parameters due to variability in 
the execution point (Richmond and Williamson, 1983). The above differences between 
the older studies and ours could account for the discrepancy in the obtained results. 
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Table 3.1 Cell size and G1 length of the haploid BY4741 Saccharomyces cerevisiae strain at different 
growth rates and nutrient limitations. For every reported value, the chemostats were sampled three times, 
of which the average and standard deviation is shown in each case 
Glucose limitation Nitrogen limitation D (h–
1) Measured parameter Experiment 
1 
Experiment 
2 
Experiment 
1 
Experiment 
2 
% in G1 61.3±0.3 63.1±0.6 40.0±0.4 46.0±1.0 
Cell size (µm3) 19.3±0.2 19.1±0.2 33.8±0.3 32.5±0.2 0.1 
Cell density (107 
cells/ml) 5.7±0.1 5.6±0.1 5.5±0.1 5.9±0.2 
% in G1 57.7±0.6 57.4±0.5 40.3±0.7 44.6±1.0 
Cell size (µm3) 18.4±0.2 19.2±0.3 29.6±0.1 29.5±0.3 0.15 
Cell density (107 
cells/ml) 5.6±0.1 5.3±0.02 4.9±0.1 4.6±0.2 
% in G1 52.1±0.4 49.7±0.5 34.4±0.3 40.3±0.9 
Cell size (µm3) 18.1±0.6 17.6±0.1 28.8±0.1 29.8±1.0 0.20 
Cell density (107 
cells/ml) 5.2±0.04 4.1±0.1 2.6±0.2 3.6±0.1 
% in G1 48.3±0.4 46.9±0.8 38.7±0.7 37.0±0.5 
Cell size (µm3) 19.0±0.2 19.0±0.4 28.9±0.2 30.9±0.3 0.25 
Cell density (107 
cells/ml) 4.4±0.1 3.4±0.1 1.4±0.1 2.8±0.1 
% in G1 44.0±0.6 42.8±0.6 41.5±0.3 41.2±0.3 
Cell size (µm3) 18.4±0.1 19.4±0.5 30.9±0.1 29.1±0.1 0.30 
Cell density (107 
cells/ml) 2.4±0.1 1.9±0.1 0.5±0.02 0.7±0.02 
 
 
  54 
 
Cell numbers and the mean cell volume of live unfixed samples were also 
measured. Cell size remained constant at all growth rates tested (Table 3.1). This has 
been seen before for glucose-limited chemostat cultures with growth rates lower than 
0.23 h–1 (Johnston et al., 1979), although in that study it was also reported that cell size 
increased by about 30% when growth rate increased to 0.31 h–1. Another difference 
between our study and that of Johnston et al. (1979) is that the mean cell size was 
significantly smaller (by about 50%) under our conditions, reaching 19 m3 on average, 
which probably reflects the differences outlined above in media and/or strain 
background between that study and ours. 
In nitrogen-limited cultures, there was a proportional prolongation of G1 and 
non-G1 phases (Figure 3.1, Table 3.1). G1 reproducibly occupied about 40% of the total 
generation time at all growth rates tested (Figure 3.1, Table 3.1). Given the prevailing 
views mentioned above, we were surprised by the fact that G1 expansion did not 
primarily account for the increase in the generation time. Cell size also remained 
constant as a function of growth rate (Table 3.1). Nitrogen-limited cells were larger than  
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glucose-limited cells proliferating at the same rate, consistent with earlier observations 
by Adams (1977). In nitrogen-limited cultures and at low dilution rates (0.1 h–1 and 0.15 
h–1), a small fraction (<5% of total) of cells had a 3C DNA content (Figure 3.1). The 
cells in that fraction were not included in the calculations of the percent of cells in G1 
shown in Tables 3.1 and 3.2. Note, however, that if one includes this population in the 
calculations, then the fraction of G1 cells would be even lower than the estimates we 
present, further strengthening our conclusions. Finally, the prototrophic strain X2180-5B 
was also examined. In that case too, non-G1 cell cycle phases expanded during nitrogen 
limitation (Table 3.2). Thus, auxotrophic supplements do not appear to influence the 
results. Under nitrogen limitation, cells with a 3N DNA content were also present at a 
dilution rate of 0.1 h–1 but they were barely detectable at 0.15 h–1 (not shown). 
Therefore, the appearance of 3C cells at low growth rates during nitrogen limitation is 
probably not strain-specific, although their relative abundance may vary among different 
strain backgrounds. 
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Table 3.2 Cell size and G1 length of the prototrophic haploid X2180-5B S. cerevisiae strain at different 
growth rates during nitrogen limitation. For every reported value, the chemostats were sampled three 
times, of which the average and standard deviation is shown in each case. 
D (h–1) Measured parameter Experiment 1 Experiment 2 
% in G1 47.6±1.9 45.1±1.2 
Cell size (µm3) 24.5±0.2 25.0±0.3 0.1 
Cell density (108 cells/ml) 1.4±0.1 1.4±0.04 
% in G1 49.1±0.9 47.0±0.8 
Cell size (µm3) 21.7±0.3 22.4±0.1 0.15 
Cell density (108 cells/ml) 1.3±0.1 1.4±0.1 
% in G1 43.0±0.1 42.9±0.4 
Cell size (µm3) 21.0±0.4 22.0±0.3 0.20 
Cell density (108 cells/ml) 1.2±0.02 1.1±0.1 
% in G1 41.1±0.5 41.1±0.9 
Cell size (µm3) 21.9±0.1 21.9±0.4 0.25 
Cell density (108 cells/ml) 0.9±0.01 0.8±0.04 
% in G1 42.1±0.2 41.4±0.4 
Cell size (µm3) 22.4±0.1 22.4±0.04 0.30 
Cell density (108 cells/ml) 0.6±0.03 0.5±0.02 
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Cell cycle progression under the above conditions was also evaluated by 
microscopic examination of bud formation and nuclear morphology (Figure 3.2). Cells 
with one nucleus were classified as unbudded, small budded (when the fraction of the 
diameter of the bud compared to the mother cell was equal or less than 0.4), and large 
budded (when the relative bud diameter was higher than 0.4). The percentage of cells 
with a dividing (in anaphase) or fully divided (in telophase) nucleus was also measured. 
These experiments confirmed the general conclusion of the DNA content data, because 
the percentage of unbudded cells (indicative of the length of the G1 phase) was in very 
good agreement with the results of the DNA content measurements (Table 3.1). 
Interestingly, however, it appears that, compared to glucose limitation, nitrogen-limited 
cells spent more time in late stages of the cell cycle, especially in mitosis (Figure 3.2). 
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Figure 3.2 Cell and nuclear morphology as a function of growth rate under glucose (Glc) or nitrogen (N) 
limitation. The number of cells evaluated for each dilution rate and nutrient limitation is shown in 
parentheses. The strain used was the same as in Figure 3.1 (haploid BY4741 background). The cells were 
grouped in four different classes (I–IV). The fourth class was composed of cells in anaphase (IVa) and 
telophase (IVb). Representative photographs for each class are shown on top, taken from nitrogen-limited 
cells. The top panels display the nuclear morphology for each class evaluated by fluorescence microscopy, 
while the bottom panels display the overall cell morphology evaluated by phase microscopy. The 
percentage of cells in each class is shown below the corresponding panels. (The unbudded cell group 
corresponds to G1 phase cells) 
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DISCUSSION 
Experiments aimed at separating nutrient-specific from growth rate-specific 
parameters during steady-state growth were carried out and cell cycle progression was 
evaluated using modern accurate methods. We are not aware of an analogous study in S. 
cerevisiae that directly compared cell cycle profiles in nitrogen-limited versus glucose-
limited chemostats. 
The differences between glucose and nitrogen limitation (Table 3.1) argue for 
nutrient-specific effects on cell cycle progression, independent of growth rate per se. 
While glucose is mainly used for energy production, nitrogen s role is exclusively 
anabolic. Interestingly, reserve carbohydrate metabolism has been recently linked to the 
duration of the G1 phase in continuous cultures (Paalman et al., 2003). Overall, it is 
unlikely that our results reflect anomalies  peculiar to chemostat cultures. In any case, 
it is clear that glucose and nitrogen limitation differentially affect the length of the G1 
phase. Perhaps the term cell growth  is too general and does not accurately describe 
the interplay between distinct metabolic processes and cell division. 
Our results are not adequately accommodated by current ideas about how cell 
growth is coordinated with cell division. There is no question that upon starvation cells 
+exit the cell cycle and arrest in G1 (or G0). This situation, however, may not extend to 
continuously dividing cell populations. The notion that all metabolic pathways are 
somehow collectively sensed  only in G1 prior to START is very useful conceptually, 
but it might be an oversimplification. It should not be surprising that the duration of cell 
cycle phases is not fixed, but instead varies upon different nutrient and growth rate 
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limitations. This is also reflected in the different growth  requirements for cell division 
manifest among different organisms, including other fungi such as Schizosaccharomyces 
pombe and Neurospora crassa (Griffin, 1994). For example, in S. pombe, a G1 growth 
requirement is also present, but it remains cryptic because in this organism the G2/M 
transition is very sensitive to overall cell growth (Nasmyth, 1979). Although under 
nitrogen-limited chemostat conditions an exclusive G1 prolongation was observed in S. 
pombe cells (Nasmyth 1979), the different cell cycle phases were determined indirectly 
using cdc mutants, which were later shown to provide inaccurate estimates (Richmond 
and Williamson, 1983). 
Finally, several mutations are known to change the duration of individual cell 
cycle phases with negligible effects on the overall doubling time, because there are 
compensatory changes in other phases (Neufeld and Edgar, 1998; Polymenis and 
Schmidt, 1999). Variability in the duration of cell cycle phases probably allows for a 
better adjustment to different environments, which might impose different metabolic 
needs. 
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CHAPTER IV 
THE Dcr2p PHOSPHATASE TARGETS Ire1p AND 
DOWNREGULATES THE UNFOLDED PROTEIN RESPONSE IN 
Saccharomyces cerevisiae* 
 
INTRODUCTION 
The unfolded protein response (UPR) is triggered when protein synthesis exceeds 
the protein folding capacity of the cell, and also by acute 'environmental' stresses, such as 
exposure to tunicamycin or dithiothreitol, which block glycosylation or disulfide bond 
formation, respectively (Kaufman et al., 2002; Schroder et al., 2000). In yeast, inositol 
requirement 1 (Ire1p), an endoplasmic reticulum transmembrane protein with its amino-
terminal domain located in the lumen of the endoplasmic reticulum, senses unfolded 
proteins (Patil and Walter, 2001; Rutkowski and Kaufman, 2004). Ire1p has kinase and 
endonuclease activities, which reside in distinct cytosolic domains. When Ire1p dimerizes, 
it is autophosphorylated in trans, primarily on Ser 840 and Ser 841, followed by activation 
of its endonuclease activity towards its sole substrate, the homologous to Atf/Creb1 
(HAC1) messenger RNA (Niwa et al., 2005; Patil and Walter, 2001). 
__________________________ 
*Reprinted from “Dcr2 targets Ire1 and downregulates the unfolded protein response in 
Saccharomyces cerevisiae” by Guo, J., and Polymenis, M., 2006, EMBO Report, 7, 
1124-7, Copyright 2006 by European Molecular Biology Organization. 
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If Ser 840 and Ser 841 cannot be phosphorylated, for example, in Ire1p-S840A, S841A, 
UPR signaling is essentially eliminated (Shamu and Walter, 1996). 
When the UPR is not induced, the HAC1u transcript is stable in the cytosol but is 
not translated efficiently because an intron blocks its translation (Patil and Walter, 2001; 
Rutkowski and Kaufman, 2004). Active Ire1p cleaves HAC1u mRNA at two splice sites 
removing the intron, and the two exons are ligated by transfer RNA ligase, generating 
HAC1i mRNA (Sidrauski et al., 1996; Sidrauski and Walter, 1997). HAC1i is then 
translated efficiently and Hac1pi activates transcription of approximately 300 UPR target 
genes (Patil & Walter, 2001; Rutkowski & Kaufman, 2004). In addition to regulated 
HAC1 mRNA splicing, which is Ire1p dependent. HAC1 mRNA transcription is also 
regulated through an Ire1p-independent pathway (Leber et al., 2004). 
The UPR is anti-mitogenic. Constitutive expression of the intron-less HAC1i 
transcript inhibits cell proliferation in yeast (Kawahara et al., 1997). In mammalian cells, 
the UPR modulates apoptosis and also delays cell-cycle progression (Brewer and Diehl, 
2000; Brewer et al., 1999). How the UPR is activated is fairly well established, but it is 
not yet clear how it is downregulated. Given the anti-mitogenic properties of the UPR, a 
mechanism that turns off the UPR must exist. 
We had previously identified the dose-dependent cell-cycle regulator 2 (Dcr2p) 
phosphatase on the basis of its positive role in cell-cycle progression (Pathak et al., 
2004). Here we show that Dcr2p interacts with Ire1p functionally and physically, both in 
vitro and in vivo, and that Dcr2p acts antagonistically to the UPR. 
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RESULTS 
A genome-wide screen to identify cellular roles for Dcr2p. From a genetic 
screen for gene products that alter the timing of START (Bogomolnaya et al., 2004a), 
we found that over-expression of the uncharacterized ORF YLR361C accelerates 
initiation of DNA replication, while its deletion delays START completion (Pathak et 
al., 2004). Consequently, we named YLR361C DCR2 (Dosage-dependent Cell Cycle 
Regulator 2). The DCR2 ORF is predicted to encode a 578 amino acid protein similar to 
phosphoesterases, which are present in all organisms (Pathak et al., 2004). The 
phosphatase domain of Dcr2p occupies the C-terminal half of the protein (positions 244-
566). The N-terminal half of Dcr2p has no similarity to any proteins in the database.  
We had previously generated a dominant-negative DCR2 allele, by introducing 
an H338A substitution (Pathak et al., 2004). This single amino acid change in other 
phosphatases blocks hydrolysis, but allows substrate binding (Zhuo et al., 1994). Cells 
carrying the DCR2-H338A dominant-negative allele have significantly diminished 
Dcr2p function, based on the ability of this allele to block START acceleration by the 
wild type DCR2 allele (Pathak et al., 2004).  
To determine cellular roles of Dcr2p, we sought to identify genes that when 
deleted in combination with DCR2 lead to synthetic growth defects. We screened the 
homozygous diploid yeast deletion panel by introducing with rapid 96-well format 
transformations a galactose-inducible DCR2-H338A allele on a plasmid. We then looked 
for synthetic growth defects in galactose-containing media, in which DCR2-H338A 
expression is in.duced, compared to glucose-containing media when its expression is 
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repressed (Figure 4.1A). In wild type cells, over-expression of the DCR2-H338A allele 
does not significantly affect overall cell proliferation (Figure 4.1B). Growth of each 
strain carrying the galactose-inducible DCR2-H338A allele was compared to empty-
vector control transformants. In this manner, we interrogated 4,021 deletion strains, of 
which 221 initially appeared to proliferate slower in the presence of galactose. Upon re-
examination, we identified 12 deletion strains that displayed a 10-fold growth defect 
when DCR2-H338A expression was induced (Figure 4.1B).  
A previous large-scale study reported synthetic interactions between DCR2 and 
RIC1 or YPT6 (Tong et al., 2001). Ric1p acts as a GTP exchange factor for the Ypt6p 
GTPase, regulating intracellular trafficking (Siniossoglou et al., 2000). We confirmed 
these interactions, and identified additional ones involving mostly gene products with 
trafficking roles (Figure 4.2 and 4.1B). We included in this group the uncharacterized 
ORF YKL091C (SFH1), which encodes a Sec14p-like polypeptide. The functional 
significance of the interactions with Img2p (involved in mitochondrial protein synthesis), 
Rai1p (involved in rRNA processing) and Tna1p (a nicotinamide transporter) is unclear. 
Finally, since we used a dominant-negative allele for our analysis (Figure 4.1A), it is 
possible that the results we obtained underestimate the extent of genetic interactions 
involving DCR2. This might explain why Tong et al. found that double dcr2, ric1 
cells are inviable (Tong et al., 2001), as opposed to slow growing in our analysis (Figure 
4.1B). 
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Figure 4.1 A genome-wide screen to identify cellular roles for Dcr2p. (A) Schematic representation of a 
systematic introduction of a dominant-negative DCR2 allele (GAL-DCR2DN) into yeast deletion strains and 
of expected phenotypes. (B) Synthetic growth defects of deletion strains when expression of the DCR2DN 
allele was induced. Growth of the strains (all in the diploid BY4743 (BY4741/BY4742) background) 
carrying the indicated plasmids was evaluated by spotting 10-fold serial dilutions of the cultures on solid 
glucose- (Glc) or galactose-containing (Gal) synthetic complete (SC) media. The plates were incubated at 
30°C and photographed after 2 (Glc) or 4 (Gal) days.
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Dcr2p antagonizes the unfolded protein response. In a genome-wide screen to 
identify genetic interactions involving DCR2 (see previous section), we found that ire1∆ 
cells carrying a dominant-negative DCR2 allele grow poorly (Figure 4.1). Furthermore, 
most of the gene products that showed genetic interactions with DCR2 had some role in 
trafficking (Figure 4.2). Because defects in transportation trigger the UPR (Patil and 
Walter, 2001), thereby possibly explaining our findings, we examined the functional 
interactions between DCR2 and IRE1. First, we deleted both DCR2 and IRE1 and found 
that dcr2∆, ire1∆ double mutants grow extremely poorly (Figure 4.3A). We then 
artificially triggered the UPR, by blocking glycosylation with tunicamycin, and 
examined cell proliferation (Figure 4.3B). Under these conditions, loss of IRE1 is lethal 
(Figure 4.3B). It seems that altering the dosage of DCR2 impairs viability in the 
presence of tunicamycin, although not to the same extent as ire1∆ cells (Figure 4.3B). 
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Figure 4.2 Genetic interactions of DCR2. Solid lines indicate interactions identified in this study, and 
dotted lines represent interactions reported previously (Tong et al, 2001). Open reading frames with a role 
in trafficking, on the basis of the annotations of the Saccharomyces Genome Database, are underlined. 
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Figure 4.3 Unfolded protein response signaling is sensitized in DCR2 mutants. (A) Synthetic growth defects of the indicated 
strains (all in the BY4741 background) were evaluated by spotting ten-fold serial dilutions of the cultures on standard (YPD) 
medium. The plates were incubated at 30°C and photographed after 2 days. (B) Growth of the indicated strains (all in the BY4741 
background) was evaluated on solid galactose medium, containing tunicamycin or DMSO alone. The plates were incubated at 30°C 
and photographed after 4 days. (C) Steady-state levels of HAC1 and KAR2 RNA are shown on an RNA blot. Each lane was loaded 
with total RNA prepared from the indicated strains (all in the BY4741 background). The ethidium bromide (EtBr)-stained gel is 
shown at the bottom, to indicate loading. (D) The indicated strains (all in the BY4743 background) were grown in galactose-
containing medium in the presence of tunicamycin or DMSO alone, for 30 min. Cells marked as PGAL-DCR2DN or PGAL-DCR2 were 
carrying the corresponding plasmids, but were otherwise wild type. RNA was extracted and transcription–PCR products with HAC1-
specific primers were resolved by agarose gel electrophoresis and visualized with EtBr. WT, wild type. 
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We then examined splicing of HAC1 mRNA, which provides an unambiguous 
molecular metric of Ire1p activation (Niwa et al., 2005). If Dcr2p interferes with UPR 
signaling, the relative levels of the unspliced HAC1u versus the spliced HAC1i mRNA 
should change in DCR2 mutants. We monitored HAC1 splicing by RNA blotting (Figure 
4.3C) and reverse transcription–PCR (RT–PCR; Figure 4.3D). When we introduced 
endoplasmic reticulum stress, by the addition of tunicamycin for 30 min, splicing of 
HAC1 was inhibited in cells overexpressing DCR2 (Figure 4.3C,D), but not the 
catalytically inactive DCR2DN allele (Figure 4.3D). After prolonged incubation (2 h) 
with tunicamycin, HAC1u mRNA was eventually spliced in cells overexpressing DCR2 
(Figure 4.3C). We confirmed UPR induction by monitoring the mRNA levels of 
karyogamy 2 (KAR2), a UPR-responsive gene (Figure 4.2C). Our observations suggest 
that the Dcr2p phosphatase antagonizes the UPR at a step preceding HAC1u mRNA 
splicing. 
Dcr2p de-phosphorylates Ire1p. We examined whether Ire1p interacts 
physically with Dcr2p. Ire1p, when activated, is autophosphorylated at Ser 840 and Ser 
841 (Shamu and Walter, 1996). We constructed strains carrying as their sole IRE1 copy 
IRE1-S840E, S841E or IRE1-S840A, S841A mutant alleles, which mimic or abolish 
phosphorylation, respectively. The viability of cells carrying either of these alleles is 
decreased in conditions that trigger the UPR, especially for IRE1-S840A, S841A cells 
(Figure 4.4A), suggesting that reversible phosphorylation of Ire1p is important for 
proper UPR signaling. 
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Figure 4.4 Dcr2p physically interacts with Ire1p in vivo. (A) Growth of the indicated strains carrying Ser 
840 and Ser 841 substitutions (all in the BY4741 background) was evaluated on solid glucose medium. All 
the IRE1 alleles were tagged at their carboxyl terminus with the tandem affinity purification (TAP) 
epitope. The plates were incubated at 30°C and photographed after 2 days. (B) Whole-cell extracts (WCE) 
from the indicated strains were subjected to SDS–polyacrylamide gel electrophoresis either directly (right) 
or after Dcr2p was precipitated with cobalt ion beads (left). For immunoblotting (IB), we used the 
peroxidase–anti-peroxidase (PAP) reagent, which recognizes the protein A (PrA)-tagged Ire1p and Dcr2p. 
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We then examined whether Dcr2p interacts physically in vivo with mutant or 
wild-type Ire1p (Figure 4.4B). For this experiment, DCR2 was epitope tagged at its 
carboxyl terminus with the 'TAG' epitope (6×His, haemagglutinin, protein A) and it was 
expressed from a galactose-inducible promoter (Gelperin et al., 2005). IRE1 and the 
mutant IRE1 alleles were expressed as C-terminal fusions with the 'TAP' epitope 
(calmodulin-binding protein, protein A) from its chromosomal location (Ghaemmaghami 
et al., 2003). From these cells, we used cobalt ion beads to precipitate Dcr2p (through 
the 6×His epitope), and we noticed that Ire1p-S840E,S841E co-precipitated with Dcr2p 
(Figure 4.4B). We did not observe interactions between Dcr2p and wild-type Ire1p or 
Ire1p-S840A,S841A, suggesting that the glutamic acid (E) substitutions allow stable 
(and detectable) interactions with Dcr2p. These results indicate that Dcr2p interacts 
physically with Ire1p in vivo, and that this interaction is dependent on the 
phosphorylation status of Ire1p at Ser 840 and Ser 841. 
We also examined whether recombinant Dcr2p from bacteria can de-
phosphorylate recombinant Ire1p. For this experiment, we expressed in bacteria the 
cytosolic portion of Ire1p (Ire1p*), which was purified and autophosphorylated (Papa et 
al., 2003). In the presence of recombinant Dcr2p, Ire1p* was de-phosphorylated, but not 
when phosphatase activity was blocked (Figure 4.5A). Complete de-phosphorylation of 
Ire1p by Dcr2p would not be expected because some phosphates might be on sites not 
targeted by Dcr2p. Our results are consistent with the idea that Ire1p is a substrate for 
Dcr2p. 
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Figure 4.5 Dcr2p de-phosphorylates Ire1p in vitro. (A) Recombinant autophosphorylated Ire1p* was 
incubated with recombinant Dcr2p (the ×1 and ×10 designations refer to the relative amount of Dcr2p 
added to the reactions) or λ-protein phosphatase (λ-PPase), in the presence (+) or absence (-) of 
phosphatase inhibitor (PPase inh.) cocktails (cocktail I alone, or I+II), as indicated. The reactions were 
analyzed by SDS–polyacrylamide gel electrophoresis and blotting, followed by phosphoprotein-specific 
detection (top), immunoblotting with a 6×His antibody (middle) or immunoblotting with the peroxidase–
anti-peroxidase reagent (bottom). The relative amounts of phosphorylated Ire1p* detected are shown on 
the chart below; they were calculated from the relevant band intensities. (B) A schematic model of the role 
of Dcr2p as an unfolded protein response (UPR) antagonist, acting on Ire1p and before HAC1u splicing. 
ER, endoplasmic reticulum. 
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DISCUSSION 
Here, we present experiments that link the Dcr2p phosphatase with Ire1p and the 
UPR. We had originally identified Dcr2p for its pro-mitogenic properties when it is 
overexpressed (Pathak et al., 2004). This could perhaps be accounted for by Dcr2p 
acting as an Ire1p phosphatase, as endoplasmic reticulum stress arrests the cell cycle and 
the UPR is sensitive to nutrients (Kaufman et al., 2002; Schroder et al., 2000) and ATP 
levels (Papa et al., 2003). However, if Dcr2p acted solely on Ire1p to affect cell 
proliferation, cells lacking both IRE1 and DCR2 should proliferate as fast as those 
lacking IRE1 or DCR2 alone (Figure 4.3A). It is likely that Dcr2p also has an impact on 
overall cell proliferation independent of Ire1p (Pathak et al., 2004; Pathak, R., Guo, J., 
Blank, H.M. and Polymenis, M., unpublished data). 
How important is the role of Dcr2p in downregulating UPR signaling? Given the 
functional interactions between DCR2 and genes involved in trafficking in general 
(Figure 4.2)—and IRE1 in particular (Figure 4.3)—as well as the physical interactions 
between Dcr2p and Ire1p (Figure 4.4, Figure 4.5), it is reasonable to conclude that Dcr2p 
has a significant role in the UPR. This role of Dcr2p is probably shared with other 
phosphatases. Although loss of Dcr2 alone only weakly sensitizes cells to endoplasmic 
reticulum stress (Figure 4.3B; Figure 4.6), the combined loss of Dcr2p and protein 
phosphatase type 2C (Ptc1p) leads to markedly reduced viability (Figure 4.6B). Another 
phosphatase, Ptc2p, was also previously shown to de-phosphorylate Ire1 in vitro 
(Welihinda et al., 1998), and over-expression of PTC2 downregulated the UPR 
(Welihinda et al., 1998). It is important to note, however, that Ptc2p and Ire1p have not 
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been shown to associate in vivo and genetic interactions of PTC2 with IRE1 or any other 
gene involved in secretion and/or transportation have not been reported. Finally, 
although Dcr2p levels are not affected by the UPR, Dcr2p seems to be post-
translationally modified when the UPR is triggered (Figure 4.7), indicating some kind of 
feedback control. Overall, it is clear that de-phosphorylation of Ire1p provides a 
mechanism for turning off the UPR after it is activated (Figure 4.5B). Other mechanisms 
that downregulate the UPR in yeast must certainly exist, especially because Ire1p-
independent pathways also contribute to UPR signaling (Leber et al., 2004; Schroder et 
al., 2003). 
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Figure 4.6 HAC1 splicing recovery in DCR2 mutants and genetic interaction between DCR2 and PTC1. 
(A) Cells lacking DCR2 recover from ER stress with near-normal kinetics. Steady-state levels of HAC1 
were evaluated as in Figure 2C. Where indicated, cells were treated with tunicamycin for 1h, and then 
grown in drug-free medium for the indicated time. The relative ratio of the unspliced (HAC1u) vs. the 
spliced (HAC1i) form of HAC1 is shown at the bottom of the HAC1 blots, from the intensity of the 
relevant bands. (B) Genetic interactions involving DCR2, PTC1 and PTC2. Growth of the indicated strains 
(all in the BY4741 background) was evaluated by spotting 10-fold serial dilutions of the cultures on solid 
galactose medium, containing tunicamycin or DMSO alone. The plates were incubated at 30°C and 
photographed after 4 days. 
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Figure 4.7 Dcr2p is modified under ER stress. The levels of Myc-tagged Dcr2p were evaluated by SDS-
PAGE and immunoblotting, after exposure to tunicamycin for the indicated time. A non-specific band is 
designated with an asterisk (*), and indicates loading. 
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CHAPTER V 
SUMMARY AND PROSPECTIVE STUDIES 
 
The dissertation is composed of two parts: 
PART ONE 
All proliferating cells have to coordinate their overall growth with cell division. 
Tight coordination between cell growth and division determines when cells initiate cell 
division. Current models predict that only in the G1 phase of the cell cycle cells monitor 
their growth. In this study, we test these models using continuous chemostat cultures, 
where growth rate was varied independently of nutrient composition. First, during five 
different growth rates, cell size was constant in either glucose- or nitrogen-limitated 
continuous cultures, but it was different between the two nutrients. This indicates that 
cell size varies as a function of nutrient composition, but not as a function of growth 
rate. Second, during five different growth rates, the duration of the G1 phase only 
predominantly expands under glucose limitation as growth rate decreases, whereas all 
cell cycle phases proportionally expand under nitrogen limitation. This indicates that 
there are nutrient-specific effects on cell cycle progression, which are independent of 
growth rate. Together, these results strongly suggest that it is unlikely that in 
continuously proliferating cells “cell growth” is exclusively monitored at the START 
point of the cell cycle in G1. 
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PART TWO 
The endoplasmic reticulum (ER) is not only a processing plant for the maturation 
of proteins but also the first compartment in the ordered membranous network for 
secretion, which is essential to all eukaryotic cells. The balance between the load of 
client proteins into the ER and the transportation of client proteins out of the ER is 
required for the normal physiological function of the ER. Perturbation to the ER 
homeostasis will result in the accumulation of unfolded proteins and cause ER stress. 
Eukaryotic cells, including budding yeast, turn on the unfolded protein response (UPR) 
signaling pathway to restore the homeostasis. Due to the anti-mitogenic effects of UPR 
signaling, cells have to turn it off ultimately. In this study, we demonstrate how the 
Dosage-dependent Cell cycle Regulator (Dcr2p) phosphatase down-regulates UPR 
signaling in Saccharomyces cerevisiae, using both genetic and biochemical approaches. 
First, a genome-wide genetic screen indicates that Dcr2p has a role in the unfolded 
protein response, because we identified interactions with nine known genes involved in 
secretion/UPR. We further confirmed the synthetic growth defects upon combined loss 
of DCR2 and IRE1, the major initiator and transducer gene for UPR signaling. Second, 
over-expression of the catalytically active Dcr2p can antagonize UPR signaling under 
ER stress, by significantly attenuating HAC1 mRNA splicing, the major transcription 
factor for activating UPR target genes. Lastly, Dcr2p physically interacts with Ire1p in 
vivo in an Ire1p phosphorylation dependent manner, and Dcr2p can directly de-
phosphorylate autophosphorylated Ire1p in vitro. Together, these experiments support 
our model that Dcr2p targets Ire1p and downregulates the unfolded protein response in 
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Saccharomyces cerevisiae. Our results are significant because, for the first time, we have 
a mechanism of how to turn off the anti-mitogenic UPR signaling, by directly 
modulating Ire1p activity, the major component of the UPR. 
In the future, it will be very interesting and meaningful to further pursue what 
kind of post-translational modifications of Dcr2p are under the ER stress, and how these 
modifications affect the function of Dcr2p on UPR signaling. The answers to these 
questions will likely help us understand what kind of feedback mechanism of ER stress 
to Dcr2p, which would present us more clues about how UPR modulation is achieved. In 
addition, further clarification of the roles of other potential phosphatase, such as Ptc1p, 
on UPR signaling will be very helpful for us to have a bigger picture of phosphatase on 
UPR signaling. The difference of how UPR signaling is downregulated (recovery of 
HAC1 mRNA splicing and its translational block) between cells under the nutrient 
sensing and chemical induced ER stress implies that the modulation of UPR signaling is 
regulated in a subtle and signal-dependent manner, possibly through different 
mechanisms. The UPR signaling modulation is still mysterious. Because of the 
importance of modulating UPR signaling in pathology, works on this will have a great 
prospective significance. 
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